Research Portfolio

Funding Opportunities

Join our Mailing List
Join our mailing list to be notified of new funding opportunities.

Your Email

To receive information about funding opportunities, events, and program updates.



Research Project Awards

2015 (Cycle 24)
Cytotoxicity and Stress Induction by Thirdhand Smoke 2015 (Cycle 24) $443,453
University of California, Riverside Environmental Exposure/Toxicology

Using technology to help low-income and Latino smokers quit 2015 (Cycle 24) $520,420
Palo Alto University, Inc. Disparities /Prevention/ Cessation/ Nicotine Dependence

Prevention of relapse in nicotine dependence: role of mGluR7 2015 (Cycle 24) $421,875
University of California, San Diego Disparities /Prevention/ Cessation/ Nicotine Dependence

The role of PACAP/PAC1 receptor system in nicotine addiction 2015 (Cycle 24) $490,832
Western University of Health Sciences Disparities /Prevention/ Cessation/ Nicotine Dependence

A novel imaging technology for the early detection of Oral C 2015 (Cycle 24) $421,842
University of California, Los Angeles Early Diagnosis/Pathogenesis

Tobacco Treatment for Employable Californians 2015 (Cycle 24) $573,934
Stanford University Disparities /Prevention/ Cessation/ Nicotine Dependence

Role of Glutamate/ACh co-release in nicotine addiction 2015 (Cycle 24) $421,875
University of California, San Diego Disparities /Prevention/ Cessation/ Nicotine Dependence

Smoking and Embryonal Tumor Study 2015 (Cycle 24) $450,835
University of California, Los Angeles Regulatory Science/New Products

The Role of CSN6 in Cardiac Muscle and Sudden Cardiac Death 2015 (Cycle 24) $421,875
University of California, San Diego Early Diagnosis/Pathogenesis

Metabolic consequences of tobacco toxicants 2015 (Cycle 24) $421,875
University of California, San Diego Early Diagnosis/Pathogenesis

Controlled Thirdhand Smoke Exposure Core 2015 (Cycle 24) $304,957
University of California, San Francisco Environmental Exposure/Toxicology

Electronic Nicotine Delivery Systems and California Youth 2015 (Cycle 24) $571,269
HBSA, Inc. Regulatory Science/New Products

Genotoxicity and Novel Biomarkers of Thirdhand Smoke 2015 (Cycle 24) $648,322
Lawrence Berkeley National Laboratory Environmental Exposure/Toxicology

DUAL USE OF MARIJUANA AND TOBACCO: SOCIAL MEDIA AND YOUTH 2015 (Cycle 24) $566,562
HBSA, Inc. Disparities /Prevention/ Cessation/ Nicotine Dependence

Airway inflammation in the evolution of airway fibrosis 2015 (Cycle 24) $421,875
University of California, San Francisco Early Diagnosis/Pathogenesis

Air pollution, tobacco smoke, & asthma in minority children 2015 (Cycle 24) $419,485
University of California, San Francisco Environmental Exposure/Toxicology

Population studies of new tobacco products and cigarettes 2015 (Cycle 24) $421,403
University of California, San Diego Regulatory Science/New Products

The Cost of Smoking for CA's Racial/Ethnic Communities 2015 (Cycle 24) $165,972
University of California, San Francisco Disparities /Prevention/ Cessation/ Nicotine Dependence

2014 (Cycle 23)
Biological Impact of E-Cigarettes on Lung Carcinogenesis 2014 (Cycle 23) $445,314
University of California, Los Angeles Regulatory Science/New Products

Early Diagnosis/Pathogenesis of Tobacco-Related Lung Disease 2014 (Cycle 23) $675,093
Scripps Research Institute Early Diagnosis/Pathogenesis

Genomic Signatures of CVD in Twins Discordant for Smoking 2014 (Cycle 23) $461,488
University of California, San Diego Early Diagnosis/Pathogenesis

Tobacco Use Disparities in Californias Priority Populations 2014 (Cycle 23) $127,634
Claremont Graduate University Disparities /Prevention/ Cessation/ Nicotine Dependence

Tobacco Use Disparities in Californias Priority Populations 2014 (Cycle 23) $359,758
University of California, San Diego Disparities /Prevention/ Cessation/ Nicotine Dependence

Perinatal Tobacco Exposure Epigenetics & Transgenerational 2014 (Cycle 23) $445,312
LA Biomedical Research Institute at Harbor-UCLA Medical Center Environmental Exposure/Toxicology

ENDS on campus: Changes in policy and retail environments 2014 (Cycle 23) $530,987
Stanford University Industry Influence/Policy

Assessing Toxicity of Tobacco Product Waste to Humans 2014 (Cycle 23) $536,478
San Diego State University Research Foundation Environmental Exposure/Toxicology

2013 (Cycle 22)
Health and economic toll of tobacco on CA's LGBT community 2013 (Cycle 22) $375,845
University of California, San Francisco Disparities /Prevention/ Cessation/ Nicotine Dependence

Economic impact of tobacco taxes on African Americans 2013 (Cycle 22) $467,178
University of California, San Francisco Disparities /Prevention/ Cessation/ Nicotine Dependence

A Family-Based Approach To Reduce Smoking in Vietnamese Men 2013 (Cycle 22) $511,465
University of California, San Francisco Disparities /Prevention/ Cessation/ Nicotine Dependence

African American Perceptions of Tobacco Denormalization Appr 2013 (Cycle 22) $600,361
HBSA, Inc. Disparities /Prevention/ Cessation/ Nicotine Dependence

GIS tools for surveillance and regulation of flavored OTPs 2013 (Cycle 22) $566,132
Stanford University Industry Influence/Policy

Social media messaging and public health campaigns: Prop 29 2013 (Cycle 22) $290,315
University of California, San Diego Industry Influence/Policy

Developmental Nicotine Exposure and Addiction 2013 (Cycle 22) $348,348
University of California, Los Angeles Disparities /Prevention/ Cessation/ Nicotine Dependence

Toward Smoke-Free Casinos: The Win-River Experience 2013 (Cycle 22) $269,209
San Diego State University Research Foundation Environmental Exposure/Toxicology

Shared Genetics of COPD and Lung Cancer 2013 (Cycle 22) $561,107
Kaiser Foundation Research Institute Early Diagnosis/Pathogenesis

Developmental Nicotine Exposure and Addiction 2013 (Cycle 22) $102,816
University of California, Irvine Disparities /Prevention/ Cessation/ Nicotine Dependence

Metals and nanoparticles in electronic cigarette aerosol 2013 (Cycle 22) $270,160
University of California, Riverside Regulatory Science/New Products

Early Detection of Stroke and Cardiovascular Disease Risk 2013 (Cycle 22) $586,770
Children's Hospital Oakland Research Institute Early Diagnosis/Pathogenesis

Joint roles of ceramide, EGFR/Src in lung injury and cancer 2013 (Cycle 22) $467,606
University of California, Davis Early Diagnosis/Pathogenesis

Effects of THS toxins on mechanical and drug-induced injury 2013 (Cycle 22) $450,896
University of California, Riverside Environmental Exposure/Toxicology

Ultra Low Dose, Effective CT for Lung Cancer Screening 2013 (Cycle 22) $428,183
University of California, Los Angeles Early Diagnosis/Pathogenesis

2012 (Cycle 21)
African American Smoking and Quitting in California 2012 (Cycle 21) $382,402
Claremont Graduate University Disparities /Prevention/ Cessation/ Nicotine Dependence

Preventing and Reducing Tobacco Use Among Homeless Youth 2012 (Cycle 21) $879,484
RAND Corporation Disparities /Prevention/ Cessation/ Nicotine Dependence

Third hand smoke and hypersensitivity 2012 (Cycle 21) $668,192
Stanford University Environmental Exposure/Toxicology

Suppression of lung adenocarcinoma by miR-34 microRNAs 2012 (Cycle 21) $459,900
University of California, Berkeley Early Diagnosis/Pathogenesis

Barriers to Blue-Collar HMO Smoking Cessation Participation 2012 (Cycle 21) $710,025
HBSA, Inc. Disparities /Prevention/ Cessation/ Nicotine Dependence

Clinical Validation of Salivary Oral Cancer Biomarkers 2012 (Cycle 21) $521,831
University of California, Los Angeles Early Diagnosis/Pathogenesis

Tobacco control policy and population-level harm reduction 2012 (Cycle 21) $459,900
University of California, San Diego Regulatory Science/New Products

Non-Nicotine Tobacco Constituents in Reward: Age Effects 2012 (Cycle 21) $275,155
University of California, Irvine Disparities /Prevention/ Cessation/ Nicotine Dependence

Certifying Smoke-Free Used Cars 2012 (Cycle 21) $686,734
San Diego State University Research Foundation Industry Influence/Policy

Fotonovela to prevent SHS exposure in multiunit housing 2012 (Cycle 21) $786,358
University of Southern California Disparities /Prevention/ Cessation/ Nicotine Dependence

2008 (Cycle 17)
Negative effects of smoke on novel HDL mimetic therapies 2008 (Cycle 17) $657,970
Lawrence Berkeley National Laboratory Cardiovascular Disease

ApoE related effect of smoking in cardiovascular disease 2008 (Cycle 17) $678,561
Children's Hospital Oakland Research Institute Cardiovascular Disease

Nicotine and congenital heart disease 2008 (Cycle 17) $629,797
Stanford University Cardiovascular Disease

Role of oxidative stress and mitochondria in COPD 2008 (Cycle 17) $615,251
University of Southern California General Biomedical Science

Tobacco, Nitrosamines, Damage, Repair, Mutations, and Cancer 2008 (Cycle 17) $654,674
Beckman Research Institute of the City of Hope Cancer

Measuring prenatal tobacco exposure in newborn blood spots 2008 (Cycle 17) $506,839
Sequoia Foundation Epidemiology

A Novel Approach to Prevent in Utero Nicotine Lung Injury 2008 (Cycle 17) $564,957
LA Biomedical Research Institute at Harbor-UCLA Medical Center General Biomedical Science

Low-Cost Contingency Management for Smoking Cessation 2008 (Cycle 17) $478,743
University of California, San Francisco Tobacco-Use Prevention and Cessation

Smokefree Homes and Smoking Initiation in a National Sample 2008 (Cycle 17) $477,781
University of California, San Diego Public Health, Public Policy, and Economics

Preserving At Risk Tobacco Control Policy Resources 2008 (Cycle 17) $392,644
University of California, San Francisco Public Health, Public Policy, and Economics

Pharmacogenomics of New Generation Platinums in Lung Cancer 2008 (Cycle 17) $394,380
University of California, San Francisco Cancer

Dissemination of the Rx for Change in Psychiatry Curriculum 2008 (Cycle 17) $30,177
Stanford University Tobacco-Use Prevention and Cessation

Chronic nicotine treatment in primates; role of a6b2 nAChRs 2008 (Cycle 17) $382,500
SRI International Nicotine Dependence

Dissemination of the Rx for Change in Psychiatry Curriculum 2008 (Cycle 17) $409,106
University of California, San Francisco Tobacco-Use Prevention and Cessation

Smoking Policies and Secondhand Smoke in Hotel Rooms 2008 (Cycle 17) $522,544
San Diego State University Research Foundation Public Health, Public Policy, and Economics

Nicotine Self-Administration in an Animal Model 2008 (Cycle 17) $720,434
Scripps Research Institute Nicotine Dependence

Nicotinic receptors in nicotine addiction 2008 (Cycle 17) $634,743
California Institute of Technology Nicotine Dependence

Chronic nicotine treatment in primates; role of a6b2 nAChRs 2008 (Cycle 17) $194,628
The Parkinson's Institute Nicotine Dependence

Novel Extracellular Sulfatases and Smoke-induced Lung Cancer 2008 (Cycle 17) $394,380
University of California, San Francisco Cancer

The impact of secondhand smoke exposure on COPD outcomes 2008 (Cycle 17) $492,890
University of California, San Francisco Epidemiology

Analysis of the Hippo pathway in lung cancer 2008 (Cycle 17) $654,999
Beckman Research Institute of the City of Hope Cancer

Association of Outlet Density with Smoking and Pack Price 2008 (Cycle 17) $515,010
Stanford University Public Health, Public Policy, and Economics

Cigarette smoke injures lung epithelium by activating nSMase 2008 (Cycle 17) $394,380
University of California, Davis Pulmonary Disease

2007 (Cycle 16)
Molecular Dynamics & Regulation of Apo A-I's Conformation 2007 (Cycle 16) $644,293
Children's Hospital Oakland Research Institute Cardiovascular Disease

Impact of MPO in Tobacco-related Cardiovascular Disease 2007 (Cycle 16) $545,359
Sidney Kimmel Cancer Center Cardiovascular Disease

Epigenetic Regulation of Airway MUC gene expression by smoke 2007 (Cycle 16) $419,528
University of California, Davis Pulmonary Disease

Macrophage DAP12 pathway in emphysema 2007 (Cycle 16) $387,237
University of California, San Francisco Pulmonary Disease

Social Context of Smoking in Adolescence and Young Adulthood 2007 (Cycle 16) $791,718
RAND Corporation Epidemiology

Hypnosis for Smoking Relapse Prevention 2007 (Cycle 16) $506,230
University of California, San Francisco Tobacco-Use Prevention and Cessation

Toxic and irritant pollutants from aged secondhand smoke 2007 (Cycle 16) $715,914
Lawrence Berkeley National Laboratory General Biomedical Science

Exposure to Secondhand Smoke: Effects of Proximity 2007 (Cycle 16) $628,932
Stanford University Public Health, Public Policy, and Economics

Gastroschisis: maternal smoking and genetic variation 2007 (Cycle 16) $668,429
Children's Hospital Oakland Research Institute General Biomedical Science

Effects of nicotine on fetal hematopoiesis 2007 (Cycle 16) $764,400
Torrey Pines Institute for Molecular Studies General Biomedical Science

Impact of MPO in Tobacco-related Cardiovascular Disease 2007 (Cycle 16) $267,555
The Burnham Institute for Medical Research Cardiovascular Disease

Modulating TLR9 Activation for Lung Cancer Therapy 2007 (Cycle 16) $415,463
The Burnham Institute for Medical Research Cancer

Modulating TLR9 Activation for Lung Cancer Therapy 2007 (Cycle 16) $100,481
Sidney Kimmel Cancer Center Cancer

Modulating TLR9 Activation for Lung Cancer Therapy 2007 (Cycle 16) $246,467
Scripps Research Institute Cancer

High Resolution OCT for Early Airway Cancer Detection 2007 (Cycle 16) $480,636
University of California, Irvine Cancer

Economic Impact of Secondhand Smoke for Communities of Color 2007 (Cycle 16) $216,038
University of California, San Francisco Public Health, Public Policy, and Economics

Tobacco Industry Targeting of Older Persons 2007 (Cycle 16) $509,993
University of California, San Francisco Public Health, Public Policy, and Economics

Understanding Nicotinic Receptor Subtype Specificity 2007 (Cycle 16) $592,751
California Institute of Technology Nicotine Dependence

Brain nAChR Occupancy: Effect of Secondhand Smoke 2007 (Cycle 16) $623,593
Brentwood Biomedical Research Institute Nicotine Dependence

Nicotinic Manipulation of the Hippocampus 2007 (Cycle 16) $420,000
University of California, San Diego Nicotine Dependence

2006 (Cycle 15)
Unraveling lung cancer signaling pathways 2006 (Cycle 15) $780,780
Scripps Research Institute Cancer

Culture and Tobacco Among American Indian Adolescents 2006 (Cycle 15) $824,825
University of Southern California Epidemiology

Sociocultural Determinants of Menthol Smoking Among Blacks 2006 (Cycle 15) $746,567
Charles R. Drew University of Medicine & Science Epidemiology

Simple Exposure Indicators for Secondhand Tobacco Smoke 2006 (Cycle 15) $280,684
Lawrence Berkeley National Laboratory General Biomedical Science

Oxidative stress and skeletal muscle dysfunction in COPD 2006 (Cycle 15) $569,914
University of California, San Diego Pulmonary Disease

Mechanisms of targeted therapy resistance in lung cancer 2006 (Cycle 15) $358,500
University of California, Los Angeles Cancer

NF-kB mediated inflammation in tobacco-induced lung cancer 2006 (Cycle 15) $420,000
University of California, San Diego Cancer

Activation and detoxification of lung cancer carcinogens 2006 (Cycle 15) $420,000
University of California, San Diego Cancer

Sex differences in nicotine effects on inflammation 2006 (Cycle 15) $410,570
University of California, San Francisco Cardiovascular Disease

Nicotine-dependent recruitment of vascular progenitor cells 2006 (Cycle 15) $799,907
The Burnham Institute for Medical Research Cardiovascular Disease

Effect of Maternal Smoking on Early Human Development 2006 (Cycle 15) $489,025
University of California, San Francisco General Biomedical Science

Pharmacogenetics of Smoking Cessation 2006 (Cycle 15) $653,384
Stanford University Tobacco-Use Prevention and Cessation

Neurobiological substrates of nicotine addiction 2006 (Cycle 15) $419,503
University of California, San Diego Nicotine Dependence

Immune Targeted Therapy for Lung Cancer 2006 (Cycle 15) $419,500
University of California, Los Angeles Cancer

Use of Existing Data to Develop Tobacco Control Strategies 2006 (Cycle 15) $418,699
University of California, San Diego Public Health, Public Policy, and Economics

Genes affecting nicotine response in C. elegans 2006 (Cycle 15) $100,000
University of California, San Diego Nicotine Dependence

Smoking Policies and Secondhand Smoke in Rental Cars 2006 (Cycle 15) $609,852
San Diego State University Research Foundation Public Health, Public Policy, and Economics

Cotinine Metabolism in Infants and Children 2006 (Cycle 15) $509,473
University of California, San Francisco Public Health, Public Policy, and Economics

Reaching and Treating LGBT Smokers: The Internet and NRT 2006 (Cycle 15) $509,201
University of California, San Francisco Tobacco-Use Prevention and Cessation

Clinical Pharmacology of Tobacco Alkaloids 2006 (Cycle 15) $508,848
University of California, San Francisco General Biomedical Science

2005 (Cycle 14)
Context & consequenes of smoking in a blue-collar cohort 2005 (Cycle 14) $426,555
Pacific Institute for Research and Evaluation Epidemiology

Effect of smoke and gender on bronchiolar injury and repair 2005 (Cycle 14) $418,207
University of California, Davis Pulmonary Disease

Improved chemoradiotherapy of lung cancer 2005 (Cycle 14) $659,033
California Pacific Medical Center Research Institute Cancer

Use of entertainment education on TV to deter youth smoking 2005 (Cycle 14) $509,320
University of California, Irvine Public Health, Public Policy, and Economics

cGMP regulation of vascular smooth muscle differentiation 2005 (Cycle 14) $403,818
University of California, San Diego Cardiovascular Disease

Nicotine & behavioral regulation in adult ADHD 2005 (Cycle 14) $495,079
University of California, Irvine Tobacco-Use Prevention and Cessation

Regulations of phase II genes by oxidation products 2005 (Cycle 14) $419,057
University of California, Merced General Biomedical Science

Heparan sulfate small molecules for contro tumor cell growth 2005 (Cycle 14) $626,807
California Institute of Technology General Biomedical Science

Neuronal oxidative stress from mild carbon monoxide exposure 2005 (Cycle 14) $417,403
University of California, Los Angeles General Biomedical Science

ETS Effects on Lung Surfactant 2005 (Cycle 14) $418,874
University of California, Santa Barbara General Biomedical Science

SHS Exacerbates cerebral ischemia: endothelial mechanisms 2005 (Cycle 14) $654,849
Stanford University Cardiovascular Disease

Mild carbon monoxide exposure impairs the inner ear 2005 (Cycle 14) $397,297
University of California, Los Angeles General Biomedical Science

Human oocyte development and PAH exposure 2005 (Cycle 14) $158,034
Stanford University General Biomedical Science

Diabetes & tobacco exposure in So CA American Indians 2005 (Cycle 14) $468,020
University of California, San Diego Epidemiology

Role of protein phosphatase 2A in lung cancer 2005 (Cycle 14) $384,497
University of California, San Diego Cancer

Relationship of perceived risks and benefits to teen smoking 2005 (Cycle 14) $532,037
University of California, San Francisco Epidemiology

Conformationally constrained nicotine vaccines 2005 (Cycle 14) $778,921
Scripps Research Institute Nicotine Dependence

A stage-based scheduled smoking intervention for Chinese 2005 (Cycle 14) $554,500
University of California, San Francisco Tobacco-Use Prevention and Cessation

Role of Pneumocystis in COPD Progression 2005 (Cycle 14) $512,737
University of Southern California Pulmonary Disease

A novel approach to prevent in utero nicotine lung injury 2005 (Cycle 14) $597,916
LA Biomedical Research Institute at Harbor-UCLA Medical Center General Biomedical Science

Effects of Outlet/Ad Density on Teen Smking and Brand Choice 2005 (Cycle 14) $410,979
Stanford University Public Health, Public Policy, and Economics

Human oocyte development and PAH exposure 2005 (Cycle 14) $260,944
University of California, San Francisco General Biomedical Science

2004 (Cycle 13)
How do nic and cig smoke affect neural control of breathing? 2004 (Cycle 13) $392,620
University of California, Los Angeles Pulmonary Disease

Effects of tobacco-induced gamete damage on embryogenesis 2004 (Cycle 13) $158,853
Lawrence Livermore National Laboratory General Biomedical Science

Tobacco use and atherosclerosis protection by paraoxonase 2004 (Cycle 13) $729,234
Scripps Research Institute Cardiovascular Disease

Fertility smoking and early mammalian development 2004 (Cycle 13) $392,451
University of California, Riverside General Biomedical Science

Lifetime passive smoke exposure and breast cancer in the CTS 2004 (Cycle 13) $122,659
Public Health Institute Epidemiology

The role of PARC in pulmonary inflammation 2004 (Cycle 13) $812,863
La Jolla Institute for Molecular Medicine Pulmonary Disease

SHS enhances cough via plasticity of brainstem neurons 2004 (Cycle 13) $387,150
University of California, Davis Pulmonary Disease

Tobacco exposure in pregnant women in minority populations 2004 (Cycle 13) $469,727
Sequoia Foundation Epidemiology

Effectiveness of a large prenatal tobacco reduction program 2004 (Cycle 13) $425,181
Sequoia Foundation Epidemiology

Effects of tobacco-induced gamete damage on embryogenesis 2004 (Cycle 13) $607,787
Lawrence Berkeley National Laboratory General Biomedical Science

Effects of pro and anti-smoking cues in stores on craving 2004 (Cycle 13) $373,894
Stanford University Public Health, Public Policy, and Economics

Supply & demand for tobacco dependence coverage 2004 (Cycle 13) $89,145
University of California, Berkeley Public Health, Public Policy, and Economics

COX-2 regulation of vaccination responses in lung cancer 2004 (Cycle 13) $379,362
University of California, Los Angeles Cancer

Expos children to secondhand smoke through cntaminated homes 2004 (Cycle 13) $754,504
San Diego State University Research Foundation Epidemiology

Ethnicity and school-level effect on CA student tobacco use 2004 (Cycle 13) $420,713
University of California, Los Angeles Epidemiology

Lifetime passive smoke exposure and breast cancer in the CTS 2004 (Cycle 13) $285,300
Cancer Prevention Institute of California Epidemiology

Lesbian, gay, bisexual and transgender tobacco use 2004 (Cycle 13) $302,119
Kaiser Foundation Research Institute Epidemiology

Environmental contexts of smoking for Southeast Asians 2004 (Cycle 13) $726,834
Pacific Institute for Research and Evaluation Epidemiology

Corporate strategies: design, conduct, publication of resrch 2004 (Cycle 13) $407,567
University of California, San Francisco Public Health, Public Policy, and Economics

Women and smoking: from adolescence to young adulthood 2004 (Cycle 13) $737,742
RAND Corporation Epidemiology

Oral clefts, smoking & variation of toxin biotransformation 2004 (Cycle 13) $623,472
Children's Hospital Oakland Research Institute General Biomedical Science

Vitamin A derivatives as antagonists of nicotine effects 2004 (Cycle 13) $670,085
The Burnham Institute for Medical Research Cancer

Disproportionate cost of smoking for communities of color 2004 (Cycle 13) $278,980
University of California, San Francisco Public Health, Public Policy, and Economics

Preserving at-risk tobacco control policy resources 2004 (Cycle 13) $392,344
University of California, San Francisco Public Health, Public Policy, and Economics

Nonsmokers helping smokers and the role of culture 2004 (Cycle 13) $476,656
University of California, San Diego Tobacco-Use Prevention and Cessation

Internet health research center: smoking, Latinos, & the Web 2004 (Cycle 13) $535,096
University of California, San Francisco Tobacco-Use Prevention and Cessation

IAP Antagonists for lung cancer treatment 2004 (Cycle 13) $727,658
The Burnham Institute for Medical Research Cancer

2003 (Cycle 12)
Nicotine self-administration in an animal model 2003 (Cycle 12) $660,156
Scripps Research Institute Nicotine Dependence

Hyperactive nicotine receptors 2003 (Cycle 12) $675,487
California Institute of Technology Nicotine Dependence

Use of existing data to dvlp new tobacco control strategies 2003 (Cycle 12) $419,888
University of California, San Diego Public Health, Public Policy, and Economics

Birth defects, smoking and host susceptibility 2003 (Cycle 12) $466,200
March of Dimes Birth Defects Foundation Epidemiology

Passive smoking, inflammatory markers and childhood asthma 2003 (Cycle 12) $508,299
University of California, San Diego Epidemiology

Neurobiological substrates of nicotine addiction 2003 (Cycle 12) $723,613
Scripps Research Institute Nicotine Dependence

Integrins and drug resistance in small cell lung cancer 2003 (Cycle 12) $780,144
The Burnham Institute for Medical Research Cancer

Effect of maternal smoking on early human development 2003 (Cycle 12) $505,975
University of California, San Francisco General Biomedical Science

LDL pathophysiology and lipoprotein structure 2003 (Cycle 12) $527,245
Children's Hospital Oakland Research Institute Cardiovascular Disease

Protective function of VEGF on the development of emphysema 2003 (Cycle 12) $420,000
University of California, San Diego Pulmonary Disease

Chemotherapeutic inhibition of polysialic acid biosynthesis 2003 (Cycle 12) $420,781
University of California, Davis Cancer

Novel Office-Based Device for Imaging Vocal Cord Cancer 2003 (Cycle 12) $510,000
University of California, Irvine Cancer

Novel DNA vaccines for the treatment of lung cancer 2003 (Cycle 12) $783,900
Scripps Research Institute Cancer

Correlates of cigarette craving in acute nicotine withdrawal 2003 (Cycle 12) $517,818
Brentwood Biomedical Research Institute Nicotine Dependence

Tobacco smoke and airway remodeling in asthma 2003 (Cycle 12) $418,951
University of California, San Diego Pulmonary Disease

Tobacco use among American Indian adolescents in California 2003 (Cycle 12) $368,975
University of Southern California Epidemiology

California AB13 compliance and ethnicity in urban bars 2003 (Cycle 12) $769,266
Pacific Institute for Research and Evaluation Public Health, Public Policy, and Economics

Correlates of cigarette craving in acute nicotine withdrawal 2003 (Cycle 12) $17,000
University of California, Los Angeles Nicotine Dependence

Smoking cessation and medical care use/costs in a large HMO 2003 (Cycle 12) $337,964
University of California, San Francisco Public Health, Public Policy, and Economics

Smoking prevention for Asian-American college students 2003 (Cycle 12) $679,368
Veterans Medical Research Foundation Tobacco-Use Prevention and Cessation

Bupropion for hospital-based smoking cessation 2003 (Cycle 12) $478,065
University of California, San Francisco Tobacco-Use Prevention and Cessation

Smoking, insulin resistance, and endothelial dysfunction 2003 (Cycle 12) $814,989
Stanford University Cardiovascular Disease

Geography of underage tobacco retail sales in Los Angeles 2003 (Cycle 12) $622,260
Pacific Institute for Research and Evaluation Public Health, Public Policy, and Economics

Does tobacco exposure delay conception? 2003 (Cycle 12) $447,845
Sequoia Foundation Epidemiology

Controlled study of withdrawal symptoms in teen smokers 2003 (Cycle 12) $499,890
Stanford University Nicotine Dependence

2002 (Cycle 11)
Effect of smoke and gender on bronchiolar injury and repair 2002 (Cycle 11) $413,288
University of California, Davis Pulmonary Disease

Tobacco Alteration of TGF Beta3 Control of Palatogenesis 2002 (Cycle 11) $680,175
University of Southern California General Biomedical Science

Smoking induced dopamine release: buproprion effects 2002 (Cycle 11) $659,060
Brentwood Biomedical Research Institute Nicotine Dependence

Nicotinic receptors and Parkinson's disease 2002 (Cycle 11) $376,470
The Parkinson's Institute Nicotine Dependence

Irritant and analgesic effects of nicotine 2002 (Cycle 11) $226,650
University of California, Davis Nicotine Dependence

Immunopharmacotherapy as a treatment for nicotine addiction 2002 (Cycle 11) $515,270
Scripps Research Institute Nicotine Dependence

Effect of tobacco-related policy change on smoking behavior 2002 (Cycle 11) $303,504
University of California, San Diego Public Health, Public Policy, and Economics

Tobacco use & policies: San Diego Mexican American residents 2002 (Cycle 11) $786,750
San Diego State University Research Foundation Public Health, Public Policy, and Economics

Cardiac ion channels and tobacco-related disease 2002 (Cycle 11) $389,983
University of California, Santa Barbara Cardiovascular Disease

Nicotine and cardiac vulnerability to fibrillation 2002 (Cycle 11) $641,821
Cedars-Sinai Medical Center Cardiovascular Disease

Role of protein phosphatase 2A in lung cancer 2002 (Cycle 11) $405,795
University of California, San Diego Cancer

p53 and p14ARF: Multiple pathways of lung cancer suppression 2002 (Cycle 11) $821,050
Sidney Kimmel Cancer Center Cancer

Inflammation, innate immunity, TLRs, and atherosclerosis 2002 (Cycle 11) $697,650
Scripps Research Institute Cardiovascular Disease

Environmental tobacco smoke effects on lung surfactant 2002 (Cycle 11) $406,444
University of California, Santa Barbara Pulmonary Disease

Vascular targeting of lung tumors 2002 (Cycle 11) $830,563
Sidney Kimmel Cancer Center Cancer

Molecular predictors of oral cancer development 2002 (Cycle 11) $419,000
University of California, San Francisco Cancer

Brain imaging in nicotine addiction 2002 (Cycle 11) $419,881
University of California, Los Angeles Nicotine Dependence

Modeling cost/effectiveness of tobacco control programs 2002 (Cycle 11) $23,238
University of California, Los Angeles Public Health, Public Policy, and Economics

Novel agents for apoptosis of lung cancer 2002 (Cycle 11) $787,977
The Burnham Institute for Medical Research Cancer

Nicotinic receptors, smoking and Parkinson's Disease 2002 (Cycle 11) $765,971
Stanford University Epidemiology

Internet-enhanced proactive telephone counseling 2002 (Cycle 11) $674,731
Veterans Medical Research Foundation Tobacco-Use Prevention and Cessation

Tobacco prevention/cessation at continuation schools 2002 (Cycle 11) $848,679
University of Southern California Tobacco-Use Prevention and Cessation

Smoking and variation of cardiovascular disease genes 2002 (Cycle 11) $635,131
Children's Hospital Oakland Research Institute Epidemiology

Modeling cost/effectiveness of tobacco control programs 2002 (Cycle 11) $129,915
University of California, San Diego Public Health, Public Policy, and Economics

Tobacco industry responses to industry-focused campaigns 2002 (Cycle 11) $77,806
University of California, San Francisco Public Health, Public Policy, and Economics

Prenatal smoke exposure and age at Menarche 2002 (Cycle 11) $129,090
Sequoia Foundation Epidemiology

Nicotine-pathological angiogenesis and genetic determinants 2002 (Cycle 11) $608,420
Stanford University Cardiovascular Disease

Pager-assisted smoking cessation treatment 2002 (Cycle 11) $463,689
University of California, San Francisco Tobacco-Use Prevention and Cessation

Simple exposure indicators for ETS particles 2002 (Cycle 11) $749,647
Lawrence Berkeley National Laboratory General Biomedical Science

The geography of tobacco related disease in California 2002 (Cycle 11) $374,786
Pacific Institute for Research and Evaluation Epidemiology

2001 (Cycle 10)
Clinical pharmacology of tobacco alkaloids 2001 (Cycle 10) $373,408
University of California, San Francisco General Biomedical Science

Effect of tobacco smoke on leucocyte adhesion in vivo 2001 (Cycle 10) $1,023,946
La Jolla Institute for Molecular Medicine Pulmonary Disease

Novel regulatory mechanisms for lung cancer growth 2001 (Cycle 10) $620,032
Veterans Medical Research Foundation Cancer

Smoking and the pathogenesis of macular degeneration 2001 (Cycle 10) $316,038
University of California, Santa Barbara General Biomedical Science

Dysregulation of VSMC signaling induced by nicotine 2001 (Cycle 10) $683,510
Stanford University Cardiovascular Disease

Smoking prevention for Asian-American college students 2001 (Cycle 10) $588,595
Veterans Medical Research Foundation Epidemiology

Two approaches to referral for smoking cessation treatment 2001 (Cycle 10) $496,836
University of California, Los Angeles Tobacco-Use Prevention and Cessation

Spanish/English web site for smoking cessation trials 2001 (Cycle 10) $519,674
University of California, San Francisco Tobacco-Use Prevention and Cessation

Persistent smoking in bars: an ethnographic analysis 2001 (Cycle 10) $482,317
Pacific Institute for Research and Evaluation Public Health, Public Policy, and Economics

Model for surveillance of CA tobacco control policies 2001 (Cycle 10) $325,761
Pacific Institute for Research and Evaluation Public Health, Public Policy, and Economics

Environmental tobacco smoke exposure & adult asthma 2001 (Cycle 10) $460,032
University of California, San Francisco Epidemiology

Chemokine-based therapy for lung cancer 2001 (Cycle 10) $416,940
University of California, Los Angeles Cancer

Smoking, microsatellite instability & gastric cancers 2001 (Cycle 10) $729,199
University of Southern California Epidemiology

Transdermal nicotine for smokers with schizophrenia 2001 (Cycle 10) $640,429
LA Biomedical Research Institute at Harbor-UCLA Medical Center Tobacco-Use Prevention and Cessation

Smoking-induced oxidant stress & platelet integrin alpha.... 2001 (Cycle 10) $801,893
The Burnham Institute for Medical Research Cardiovascular Disease

Adolescent susceptibility to tobacco: a panel analysis 2001 (Cycle 10) $495,433
University of California, Irvine Epidemiology

Nicotine withdrawal, smoking & attention: an fMRI study 2001 (Cycle 10) $515,303
University of California, Los Angeles Nicotine Dependence

Analysis of California adolescent tobacco data 2001 (Cycle 10) $475,742
University of California, Los Angeles Epidemiology

Molecular neurobiology of nicotine addiction 2001 (Cycle 10) $263,298
University of California, Los Angeles Nicotine Dependence

Patterns of tobacco use from adolescence to young adulthood 2001 (Cycle 10) $431,132
RAND Corporation Epidemiology

The role of media in smoking initiation & cessation 2001 (Cycle 10) $414,203
University of California, San Diego Public Health, Public Policy, and Economics

Neurobehavioral consequences of adolescent nicotine exposure 2001 (Cycle 10) $630,710
Scripps Research Institute Nicotine Dependence

Mechanisms underlying modulations of respiration by nicotine 2001 (Cycle 10) $330,458
University of California, Los Angeles Pulmonary Disease

Cardiovascular responses through spinal nicotinic receptors 2001 (Cycle 10) $448,941
University of California, San Diego Nicotine Dependence

Effects of nicotine withdrawal on aviator performance 2001 (Cycle 10) $515,243
Stanford University Nicotine Dependence

Self-hypnosis for smoking cessation 2001 (Cycle 10) $413,119
University of California, San Francisco Tobacco-Use Prevention and Cessation

Neurobiological substrates of nicotine addiction 2001 (Cycle 10) $402,852
Scripps Research Institute Nicotine Dependence

Tobacco smoke, inflammation & atherosclerosis 2001 (Cycle 10) $754,932
Scripps Research Institute Cardiovascular Disease

Smoking and virulence of periodontal pathogens 2001 (Cycle 10) $289,574
Loma Linda University General Biomedical Science

Analysis of a lung tumor supressor gene at 3p21.3 2001 (Cycle 10) $249,438
Beckman Research Institute of the City of Hope Cancer

ApoE isoforms, fatty acid metabolism and atherosclerosis 2001 (Cycle 10) $691,616
J. David Gladstone Institutes Cardiovascular Disease

Mechanism of smoke-induced MUC5B gene expression 2001 (Cycle 10) $392,117
University of California, Davis Pulmonary Disease

Fertility, smoking and early mammalian development 2001 (Cycle 10) $454,490
University of California, Riverside General Biomedical Science

Bispecific molecular therapy of small cell lung cancer 2001 (Cycle 10) $434,805
University of California, San Diego Cancer

Anabolic therapies for muscle dysfunction in women with COPD 2001 (Cycle 10) $632,153
LA Biomedical Research Institute at Harbor-UCLA Medical Center Pulmonary Disease

2000 (Cycle 9)
Proteins involved in nicotine receptor clustering 2000 (Cycle 9) $307,246
University of California, San Diego Nicotine Dependence

Smoking, estrogen metabolites & cognitive function 2000 (Cycle 9) $193,049
University of California, San Diego Epidemiology

A dynamic model of smoking and healthcare expenditures in CA 2000 (Cycle 9) $595,843
University of California, San Francisco Public Health, Public Policy, and Economics

Chronic bronchitis: pathology of mucin gene expression 2000 (Cycle 9) $329,481
University of California, Davis Pulmonary Disease

ETS effects on breathing patterns 2000 (Cycle 9) $590,780
University of California, Davis Pulmonary Disease

Macrophage function in atherosclerosis 2000 (Cycle 9) $709,200
Scripps Research Institute Cardiovascular Disease

Chronic bronchitis: pathology of mucin gene expression 2000 (Cycle 9) $147,758
University of California, San Francisco Pulmonary Disease

Hyperactive nicotine receptors 2000 (Cycle 9) $1,138,225
California Institute of Technology Nicotine Dependence

Stress and the use of nicotine 2000 (Cycle 9) $897,484
Cedars-Sinai Medical Center Nicotine Dependence

Implementation of tobacco programs in Calif schools 2000 (Cycle 9) $765,192
University of Southern California Public Health, Public Policy, and Economics

Tobacco exposure & subclinical atherosclerosis in NIDDM 2000 (Cycle 9) $321,363
University of Southern California Epidemiology

Mechanism of nicotine action in developing lung 2000 (Cycle 9) $720,281
University of Southern California Pulmonary Disease

Pathophysiology of abnormal remnant metabolism in smokers 2000 (Cycle 9) $783,345
Palo Alto Medical Foundation Research Institute Cardiovascular Disease

Novel nicotine cessation therapeutics 2000 (Cycle 9) $802,840
Human BioMolecular Research Institute Nicotine Dependence

Behavioral effects of neonatal nicotine exposure 2000 (Cycle 9) $624,780
San Diego State University Research Foundation Nicotine Dependence

Nicotine in the Brain 2000 (Cycle 9) $518,966
University of California, San Diego Nicotine Dependence

Experimental evaluation of minors' access to tobacco 2000 (Cycle 9) $655,347
San Diego State University Research Foundation Public Health, Public Policy, and Economics

Dissuading at-risk youth from smoking via mass media 2000 (Cycle 9) $610,340
University of California, Irvine Tobacco-Use Prevention and Cessation

Analysis of tobacco industry documents on scientific researc 2000 (Cycle 9) $442,646
University of California, San Francisco Public Health, Public Policy, and Economics

Predicting progress toward cessation in California smokers 2000 (Cycle 9) $99,954
University of California, San Diego Public Health, Public Policy, and Economics

Use of existing data to develop new tobacco control strategi 2000 (Cycle 9) $402,610
University of California, San Diego Public Health, Public Policy, and Economics

Nicotine & cardiac vulnerability to fibrillation 2000 (Cycle 9) $120,000
Cedars-Sinai Medical Center Cardiovascular Disease

Effect of maternal smoking on human placental development 2000 (Cycle 9) $515,124
University of California, San Francisco General Biomedical Science

Comprehensive evaluation of the ischemic leg 2000 (Cycle 9) $672,390
Stanford University General Biomedical Science

Analysis of a candidate lung tumor suppressor gene at 3p21.3 2000 (Cycle 9) $111,910
Beckman Research Institute of the City of Hope Cancer

Improved therapy of lung cancer 2000 (Cycle 9) $668,814
California Pacific Medical Center Research Institute Cancer

Studies of novel antitumor agents for lung carcinoma 2000 (Cycle 9) $833,491
University of California, San Diego Cancer

Novel DNA vaccines for the treatment of lung cancer 2000 (Cycle 9) $1,063,300
Scripps Research Institute Cancer

Cytokine gene-modified dendritic cells for lung cancer 2000 (Cycle 9) $590,523
University of California, Los Angeles Cancer

Lung volume reduction surgery in an animal emphysema model 2000 (Cycle 9) $456,336
University of California, Irvine Pulmonary Disease

Smoking & the pathogenesis of macular degeneration 2000 (Cycle 9) $99,500
University of California, Santa Barbara General Biomedical Science

RCT of tobacco dependence treatment benefits in an HMO & PPO 2000 (Cycle 9) $582,472
University of California, Berkeley Public Health, Public Policy, and Economics

Mobilized dendritic cells for lung cancer 2000 (Cycle 9) $950,821
Stanford University Cancer

Nicotine regulates cardiac toxicity with lipopolysaccharide 2000 (Cycle 9) $100,000
University of California, San Diego Cardiovascular Disease

Proposition 99 Archives 2000 (Cycle 9) $100,000
University of California, San Francisco Public Health, Public Policy, and Economics

Role of Smad protein in growth inhibition of tumor cells 2000 (Cycle 9) $474,492
Lawrence Berkeley National Laboratory Cancer

Post-isoprenylation processing steps as anticancer targets 2000 (Cycle 9) $1,017,450
J. David Gladstone Institutes Cancer

The role of media in smoking initiation & cessation 2000 (Cycle 9) $98,395
University of California, San Diego Public Health, Public Policy, and Economics

CT imaging to assist diagnosis of solitary pulmonary nodules 2000 (Cycle 9) $59,002
University of California, Los Angeles Cancer

Effects of prenatal nicotine exposure on nicotinic receptors 2000 (Cycle 9) $471,654
University of California, San Francisco Nicotine Dependence

Tobacco use & acculturation: CA residents of Korean descent 2000 (Cycle 9) $825,701
San Diego State University Research Foundation Epidemiology

Recruitment of leucocytes to atherosclerotic lesions in vivo 2000 (Cycle 9) $175,102
University of California, San Diego Cardiovascular Disease

DNA replication, regulation of the cell cycle, and cancer 2000 (Cycle 9) $571,742
California Institute of Technology General Biomedical Science

Tests of the tobacco industry's youth smoking prevention ads 2000 (Cycle 9) $343,044
Stanford University Public Health, Public Policy, and Economics

Neurobehavioral consequences of adolescent nicotine exposure 2000 (Cycle 9) $120,000
Scripps Research Institute Nicotine Dependence

Nicotinic and Schizophrenia 2000 (Cycle 9) $87,719
University of California, Irvine Nicotine Dependence

Human neurophysiology of nicotine analgesia: sex differences 2000 (Cycle 9) $595,994
University of California, San Francisco Nicotine Dependence

Molecular origins of ApoB atherogenic lipoproteins 2000 (Cycle 9) $445,617
University of California, San Francisco Cardiovascular Disease

Telephone counseling for smokers using pharmacotherapy 2000 (Cycle 9) $774,971
University of California, San Diego Tobacco-Use Prevention and Cessation

Tobacco industry targeting of African Americans 2000 (Cycle 9) $99,680
University of California, San Francisco Public Health, Public Policy, and Economics

Determinants of smoking among gay & lesbian youth 2000 (Cycle 9) $509,771
University of California, San Francisco Epidemiology

Human tryptase gene expression: role in COPD 2000 (Cycle 9) $545,409
University of California, San Francisco Pulmonary Disease

Novel regulatory mechanisms for lung cancer growth 2000 (Cycle 9) $100,000
University of California, San Diego Cancer

Role of integrins in cardiac innervation and function 2000 (Cycle 9) $293,277
University of California, Santa Barbara Cardiovascular Disease

Nicotine effects on renal function in experimental diabetes 2000 (Cycle 9) $98,313
University of California, San Diego Cardiovascular Disease

1999 (Cycle 8)
Role of nicotine in neuro protection 1999 (Cycle 8) $722,263
The Parkinson's Institute Nicotine Dependence

Neurotransmitter systems and tobacco smoking 1999 (Cycle 8) $430,910
University of California, Los Angeles Nicotine Dependence

Nicotine May Affect Inflammation 1999 (Cycle 8) $435,425
University of California, San Francisco Nicotine Dependence

Nicotine effects on neurological development 1999 (Cycle 8) $189,233
University of California, Irvine Nicotine Dependence

Neurotoxic effects of nicotine: anatomy, mechanisms, effects 1999 (Cycle 8) $183,424
University of California, Los Angeles Nicotine Dependence

Tobacco oxidants and the ceramide path in lung cell death 1999 (Cycle 8) $427,613
University of California, Davis Pulmonary Disease

Tobacco Control Digital Library 1999 (Cycle 8) $514,796
University of California, San Francisco Public Health, Public Policy, and Economics

Supplement to tobacco disease in twins 1999 (Cycle 8) $432,989
University of Southern California Epidemiology

Ascertainment of environmental tobacco exposure in pregnancy 1999 (Cycle 8) $2,053,747
Sequoia Foundation Epidemiology

Ethnic difference in cigarette smoking dynamics among youth 1999 (Cycle 8) $366,852
University of Southern California Epidemiology

Smoking Control Policies in California Health Plans 1999 (Cycle 8) $80,542
University of California, Berkeley Public Health, Public Policy, and Economics

Economic Analysis of Smoking Cessation Therapies 1999 (Cycle 8) $270,206
University of California, San Francisco Public Health, Public Policy, and Economics

Environmental tobacco smoke effects on lung surfactant 1999 (Cycle 8) $423,216
University of California, Santa Barbara Pulmonary Disease

Effects of passive smoking and pregnancy 1999 (Cycle 8) $565,186
Lawrence Livermore National Laboratory Cancer

Vascular targeting of lung tumors 1999 (Cycle 8) $899,686
Sidney Kimmel Cancer Center Cancer

Role of protein phosphatase 2A in lung cancer 1999 (Cycle 8) $307,522
University of California, San Diego Cancer

Evaluation of office ETS exposure in relation to AB 13 1999 (Cycle 8) $242,063
Public Health Institute Public Health, Public Policy, and Economics

Novel strategy for protecting neurons from injury in stroke 1999 (Cycle 8) $742,809
Stanford University Cardiovascular Disease

Apolipoprotein E: remnant metabolism and atherogenesis 1999 (Cycle 8) $793,474
J. David Gladstone Institutes Cardiovascular Disease

Explaining racial differences in smoking 1999 (Cycle 8) $151,430
San Diego State University Research Foundation Public Health, Public Policy, and Economics

Effectiveness of two different regimens in smoking clinic 1999 (Cycle 8) $272,989
University of California, Los Angeles Nicotine Dependence

Evaluation of office ETS exposure in relation to AB13 1999 (Cycle 8) $208,554
Lawrence Berkeley National Laboratory General Biomedical Science

A longitudinal study of smoking transitions in youth 1999 (Cycle 8) $577,574
University of California, San Diego Tobacco-Use Prevention and Cessation

Explaining racial differences in smoking 1999 (Cycle 8) $149,280
Public Health Foundation Enterprises, Inc. Public Health, Public Policy, and Economics

Effect of tobacco related policy change on smoking behavior 1999 (Cycle 8) $261,672
University of California, San Diego Public Health, Public Policy, and Economics

Smoking, breast cancer and tobacco metabolizing genes 1999 (Cycle 8) $120,000
Childrens Hospital, Los Angeles Epidemiology

Smoking during pregnancy: chromosome damage in newborns 1999 (Cycle 8) $1,662,871
Lawrence Livermore National Laboratory Epidemiology

Parkinson's Disease: A Protective Effect of Smoking? 1999 (Cycle 8) $512,849
Stanford University Epidemiology

Dissemination of a smoking cessation program for in patients 1999 (Cycle 8) $710,621
Stanford University Tobacco-Use Prevention and Cessation

Detection of occult metastases in patients with lung cancer 1999 (Cycle 8) $723,842
University of Southern California Cancer

African Americans and Mentholated Cigarettes 1999 (Cycle 8) $417,968
Charles R. Drew University of Medicine & Science Nicotine Dependence

Telephone Counseling for Pregnant Smokers 1999 (Cycle 8) $828,931
University of California, San Diego Tobacco-Use Prevention and Cessation

1998 (Cycle 7)
Studies of novel antitumor agents for lung cancers 1998 (Cycle 7) $306,000
University of California, San Diego Cancer

Towards gene therapy for tobacco-related vascular disease 1998 (Cycle 7) $719,328
J. David Gladstone Institutes Cardiovascular Disease

Neurobiological substrates of nicotine addiction 1998 (Cycle 7) $742,393
Scripps Research Institute Nicotine Dependence

Will ApoE cause regression of atherosclerotic lesions? 1998 (Cycle 7) $165,299
J. David Gladstone Institutes Cardiovascular Disease

Role of nicotine/nicotinic receptors in Parkinson's disease 1998 (Cycle 7) $644,770
The Parkinson's Institute Nicotine Dependence

Transport and disposition of nicotine in the human placenta 1998 (Cycle 7) $333,108
University of California, San Francisco General Biomedical Science

Role of passive smoke on sperm, ICSI and IVF 1998 (Cycle 7) $628,862
University of California, San Diego Epidemiology

Suppressor genes of lung cancer 1998 (Cycle 7) $859,254
The Burnham Institute for Medical Research Cancer

Lipoprotein classes and susceptibility to atherosclerosis 1998 (Cycle 7) $702,940
J. David Gladstone Institutes Cardiovascular Disease

Bupropion for smoking cessation 1998 (Cycle 7) $471,154
University of California, San Francisco Nicotine Dependence

Antioxidants, cigarette smoking and atherosclerosis 1998 (Cycle 7) $730,640
University of Southern California Epidemiology

Behavioral epidemiology of tobacco use among gay men 1998 (Cycle 7) $626,433
University of California, San Francisco Epidemiology

Determining how cholesterol-rich Lp(a) causes heart disease 1998 (Cycle 7) $797,092
J. David Gladstone Institutes Cardiovascular Disease

Implementation of California AB 13: smoking ban in bars 1998 (Cycle 7) $315,181
University of California, San Francisco Public Health, Public Policy, and Economics

How does smoke activate mucin transcription in lung cells? 1998 (Cycle 7) $432,415
University of California, San Francisco Pulmonary Disease

Role of thioredoxin in ETS-induced pulmonary airway injury 1998 (Cycle 7) $425,665
University of California, Davis Pulmonary Disease

ETS exposures in the California Teachers Study cohort 1998 (Cycle 7) $449,677
Public Health Institute Epidemiology

Smoking treatment for substance abusing adolescents 1998 (Cycle 7) $431,607
University of California, San Diego Tobacco-Use Prevention and Cessation

The effect of tobacco smoke on immune function in twins 1998 (Cycle 7) $822,641
University of Southern California Epidemiology

Effect of tobacco smoke on lung airway surface liquid 1998 (Cycle 7) $115,658
Children's Hospital Oakland Research Institute Pulmonary Disease

Mechanisms by which tobacco accelerates atherosclerosis 1998 (Cycle 7) $675,731
Stanford University Cardiovascular Disease

Effect of tobacco smoke on leukocyte adhesion in vivo 1998 (Cycle 7) $754,361
La Jolla Institute for Molecular Medicine Pulmonary Disease

Vitamin E kinetics in smokers 1998 (Cycle 7) $332,110
University of California, Davis General Biomedical Science

Mechanisms underlying diaphragm adaptations in emphysema 1998 (Cycle 7) $642,624
Cedars-Sinai Medical Center Pulmonary Disease

Tobacco use and cessation among drug users 1998 (Cycle 7) $249,392
University of California, Los Angeles Epidemiology

Nitrogen Oxides and cigarette smoke-induced injury 1998 (Cycle 7) $304,118
University of California, Davis Pulmonary Disease

Oxidative damage to sperm DNA: smoking and diet interaction 1998 (Cycle 7) $155,135
University of California, Berkeley General Biomedical Science

Smoke-free bars: analysis of the response from Long Beach 1998 (Cycle 7) $552,978
California State University, Long Beach Foundation Public Health, Public Policy, and Economics

Reducing provision of tobacco to minors from social sources 1998 (Cycle 7) $639,838
Stanford University Tobacco-Use Prevention and Cessation

Natural history of tobacco addiction in adolescents 1998 (Cycle 7) $499,505
University of California, San Francisco Tobacco-Use Prevention and Cessation

Effects of tobacco smoke exposure on hormones and fertility 1998 (Cycle 7) $115,335
Sequoia Foundation Epidemiology

ETS Effects on airway development in the primate lung 1998 (Cycle 7) $483,652
University of California, Davis General Biomedical Science

Therapy for muscle dysfunction in COPD: cellular adaptations 1998 (Cycle 7) $502,904
Cedars-Sinai Medical Center Pulmonary Disease

Effects of environmental tobacco smoke on the artery wall 1998 (Cycle 7) $449,673
University of California, Davis Cardiovascular Disease

Mechanism of stress effects on weight in nicotine withdrawal 1998 (Cycle 7) $407,019
University of California, San Francisco Nicotine Dependence

Genetic susceptibility to tobacco-induced lung cancer 1998 (Cycle 7) $406,120
University of California, Los Angeles Cancer

An athletic trainer mediated spit tobacco cessation program 1998 (Cycle 7) $490,546
University of California, San Francisco Tobacco-Use Prevention and Cessation

Spanish/English web site for smoking cessation trials 1998 (Cycle 7) $450,400
University of California, San Francisco Tobacco-Use Prevention and Cessation

Programmed cell death in cigarette-induced lung disease 1998 (Cycle 7) $371,556
University of California, San Francisco Pulmonary Disease

Family factors in smoking acquisition among Latino youth 1998 (Cycle 7) $865,636
San Diego State University Research Foundation Tobacco-Use Prevention and Cessation

Developing new vaccines for lung cancer 1998 (Cycle 7) $398,511
University of California, Los Angeles Cancer

Maternal DNA repair of tobacco-induced sperm lesions 1998 (Cycle 7) $1,046,880
Lawrence Livermore National Laboratory General Biomedical Science

Keep me smokefree 1998 (Cycle 7) $550,002
Education Training and Research Associates, Inc. Tobacco-Use Prevention and Cessation

Effects of nicotine on postinfarction cardiac remodeling 1998 (Cycle 7) $459,799
University of California, San Diego Cardiovascular Disease

Effects of environmental tobacco smoke on pulmonary allergy 1998 (Cycle 7) $282,568
University of California, Davis Pulmonary Disease

Smoking and lifestyle risk factors for premenstrual changes 1998 (Cycle 7) $297,783
University of California, Davis Epidemiology

Clinical pharmacology of tobacco alkaloids 1998 (Cycle 7) $439,882
University of California, San Francisco Nicotine Dependence

Hormone replacement therapy, smoking & lipoprotein oxidation 1998 (Cycle 7) $385,808
Scripps Research Institute Cardiovascular Disease

Vapor-phase organics in ETS: dynamics and exposure 1998 (Cycle 7) $722,775
Lawrence Berkeley National Laboratory General Biomedical Science

Inflammatory compounds:role in tobacco-related lung disease 1998 (Cycle 7) $447,367
University of California, San Diego Cancer

Effects of Selegiline on craving for nicotine 1998 (Cycle 7) $100,450
Stanford University Nicotine Dependence

Carbon monoxide and the brain growth spurt 1998 (Cycle 7) $464,268
University of California, Los Angeles General Biomedical Science

Oxidative damage to sperm DNA: smoking and diet interaction 1998 (Cycle 7) $132,367
Children's Hospital Oakland Research Institute General Biomedical Science

Hormone replacement therapy, smoking & lipoprotein oxidation 1998 (Cycle 7) $245,584
La Jolla Institute for Molecular Medicine Cardiovascular Disease

1997 (Cycle 6)
ETS effects on pulmonary breathing patterns 1997 (Cycle 6) $446,954
University of California, Davis Pulmonary Disease

Nicotine and cardiac vulnerability to fibrillation 1997 (Cycle 6) $370,057
Cedars-Sinai Medical Center Cardiovascular Disease

Cardiovascular responses to nicotine 1997 (Cycle 6) $430,843
University of California, San Diego Nicotine Dependence

Preventing tobacco smoke diseases by network antioxidants 1997 (Cycle 6) $388,714
University of California, Berkeley General Biomedical Science

Smoking initiation among Chinese and Vietnames adolescents 1997 (Cycle 6) $449,734
University of California, San Francisco Tobacco-Use Prevention and Cessation

Cigarette smoke alters lipoprotein & artery wall interaction 1997 (Cycle 6) $472,876
University of California, Los Angeles Cardiovascular Disease

Transdermal nicotine replacement for hospitalized smokers 1997 (Cycle 6) $451,969
University of California, San Francisco Nicotine Dependence

Novel therapy for pancreatic cancer 1997 (Cycle 6) $452,332
University of California, Irvine Cancer

Smoking predictors in Mexican American youth 1997 (Cycle 6) $534,603
University of San Francisco Tobacco-Use Prevention and Cessation

Brain adaptations to chronic nicotine expsoure 1997 (Cycle 6) $402,111
University of California, Irvine Nicotine Dependence

Cigar smoking among young adults: formative research 1997 (Cycle 6) $292,920
California State University, Long Beach Foundation Tobacco-Use Prevention and Cessation

Development of a blood test for pancreatic cancer 1997 (Cycle 6) $308,819
Stanford University Cancer

The role of multiple genes in susceptibility to smoking 1997 (Cycle 6) $557,829
Beckman Research Institute of the City of Hope Epidemiology

Patterns of tobacco use from adolescence to young adulthood 1997 (Cycle 6) $565,277
RAND Corporation Epidemiology

Irritant and pain-reducing effects of nicotine 1997 (Cycle 6) $415,704
University of California, Davis Nicotine Dependence

Tobacco-related cancer prevention by Vitamin A derivatives 1997 (Cycle 6) $149,947
Molecular Medicine Research Institute Cancer

Tobacco-related cancer prevention by Vitamin A derivatives 1997 (Cycle 6) $274,488
SRI International Cancer

Serum cotinine levels and reproductive outcomes 1997 (Cycle 6) $452,159
Public Health Institute Epidemiology

Novel imaging methods for diagnosing tobacco related cancers 1997 (Cycle 6) $629,087
Stanford University Cancer

Effect of maternal smoking on human placental development 1997 (Cycle 6) $450,000
University of California, San Francisco General Biomedical Science

Indoor measurements of environmental tobacco smoke 1997 (Cycle 6) $634,217
Lawrence Berkeley National Laboratory General Biomedical Science

Secondhand smoke promotes chemical toxicity in fetal lung 1997 (Cycle 6) $190,536
University of California, Davis General Biomedical Science

Environmental tobacco smoke and newborn lung development 1997 (Cycle 6) $440,500
University of California, Davis General Biomedical Science

Tobacco-related disease in native California twins 1997 (Cycle 6) $889,746
University of Southern California Epidemiology

Oral clefts, smoking & variation toxin biotransformation 1997 (Cycle 6) $677,128
Children's Hospital Oakland Research Institute Epidemiology

How does cigarette smoke induce cancer? 1997 (Cycle 6) $811,518
Beckman Research Institute of the City of Hope Cancer

Therapies of muscle dysfunction in obstructive lung disease 1997 (Cycle 6) $659,714
LA Biomedical Research Institute at Harbor-UCLA Medical Center Pulmonary Disease

The role of media in smoking initiation and cessation 1997 (Cycle 6) $433,880
University of California, San Diego Epidemiology

Pediatrician training to prevent children's tobacco exposure 1997 (Cycle 6) $133,852
University of California, San Francisco Public Health, Public Policy, and Economics

Improving tobacco use assessment among youth via telephone 1997 (Cycle 6) $347,440
University of California, Berkeley Public Health, Public Policy, and Economics

Smokeless tobacco cessation among lumber mill employees 1997 (Cycle 6) $620,213
University of Southern California Tobacco-Use Prevention and Cessation

School tobacco program and policy trial 1997 (Cycle 6) $1,162,877
University of Southern California Tobacco-Use Prevention and Cessation

Quantification of lung doses from inhaled tobacco smoke 1997 (Cycle 6) $425,728
University of California, Irvine General Biomedical Science

Nicotonic receptors: role in addiction and reproduction 1997 (Cycle 6) $437,480
Salk Institute for Biological Studies Nicotine Dependence

Brachial Vasoreactivity in Young Adult Smokers 1997 (Cycle 6) $332,294
Osteoporosis Medical Center Epidemiology

Nicotine toxicity acting on cardiac neurons 1997 (Cycle 6) $446,920
University of California, San Diego Nicotine Dependence

Anti-Tobacco Programming: Reaching Deaf and Hard of Hearing 1997 (Cycle 6) $446,947
University of California, Los Angeles Tobacco-Use Prevention and Cessation

Hyperactive nicotine receptors 1997 (Cycle 6) $486,158
California Institute of Technology Nicotine Dependence

NRT and paroxetine for smoking cessation 1997 (Cycle 6) $646,916
Stanford University Nicotine Dependence

Fertility, smoking and early mammalian development 1997 (Cycle 6) $452,243
University of California, Riverside General Biomedical Science

Evaluation of ad strategies for preventing youth tobacco use 1997 (Cycle 6) $136,953
University of California, Irvine Public Health, Public Policy, and Economics

Developing treatments that lower blood cholesterol levels 1997 (Cycle 6) $746,536
Scripps Research Institute Cardiovascular Disease

Developing policy to reverse cigar trend: roles of media 1997 (Cycle 6) $249,785
University of California, San Francisco Public Health, Public Policy, and Economics

Nicotine pharmacogenetics: influence of ethnicity 1997 (Cycle 6) $366,244
LA Biomedical Research Institute at Harbor-UCLA Medical Center Nicotine Dependence

Reducing minors' access to tobacco: project CHALK 1997 (Cycle 6) $398,114
Public Health Foundation Enterprises, Inc. Tobacco-Use Prevention and Cessation

Motivation-enhanced teenage tobacco use cessation 1997 (Cycle 6) $750,248
University of Southern California Tobacco-Use Prevention and Cessation

Does nicotine inhibit anticancer activities of Vitamin A? 1997 (Cycle 6) $788,808
The Burnham Institute for Medical Research Cancer

Lung volume reduction surgery in an emphysema model 1997 (Cycle 6) $404,139
University of California, Irvine Pulmonary Disease

Aggression and Nicotine 1997 (Cycle 6) $230,826
University of California, Irvine Nicotine Dependence

Diaphragm adaptations following treatment for emphysema 1997 (Cycle 6) $469,400
Cedars-Sinai Medical Center Pulmonary Disease

Environmental tobacco smoke and early atherosclerosis 1997 (Cycle 6) $383,814
University of Southern California Epidemiology

Recruitment of leukocytes to atherosclerotic lesions in vivo 1997 (Cycle 6) $352,405
University of California, San Diego Cardiovascular Disease

Quantification of population exposure to secondhand smoke 1997 (Cycle 6) $686,858
Stanford University Epidemiology

Gene therapy for emphysema 1997 (Cycle 6) $443,179
University of California, San Francisco Pulmonary Disease

Spanish tobacco-related disease self-management: evaluation 1997 (Cycle 6) $693,751
Stanford University Tobacco-Use Prevention and Cessation

The role of nicotine receptors in nicotine dependence 1997 (Cycle 6) $381,317
University of California, Irvine Nicotine Dependence

Case studies of indoor air regulations: role of research 1997 (Cycle 6) $292,210
University of California, San Francisco Public Health, Public Policy, and Economics

Nicotine pharmacogenetics: influence of ethnicity 1997 (Cycle 6) $242,344
Cedars-Sinai Medical Center Nicotine Dependence

1995 (Cycle 4)
SAR Studies of Novel antitumor Agents for Lung Carcinomas 1995 (Cycle 4) $403,338
University of California, San Diego Cancer

Smoking, Nicotine, Sleep & Mood in Normals & Depression 1995 (Cycle 4) $207,434
University of California, San Diego Tobacco-Use Prevention and Cessation

Expression of the Human apo-B Gene in Transgenic Mice 1995 (Cycle 4) $211,090
J. David Gladstone Institutes Cardiovascular Disease

Expression of the Human apo-B Gene in Transgenic Mice 1995 (Cycle 4) $569,759
Palo Alto Medical Foundation Research Institute Cardiovascular Disease

Interactions of Moesin during platelet activation 1995 (Cycle 4) $428,524
Stanford University Cardiovascular Disease

Inheritance and Smoking in Urinary Tract & Pancreas Cancer 1995 (Cycle 4) $248,283
University of Southern California Epidemiology

Predicting and Reducing Cigarette Sales to Minors 1995 (Cycle 4) $358,643
University of Southern California Public Health, Public Policy, and Economics

Predicting and Reducing Cigarette Sales to Minors 1995 (Cycle 4) $350,549
Public Health Foundation Enterprises, Inc. Public Health, Public Policy, and Economics

Smoking Cessation in Vietnamese: A Controlled Trial 1995 (Cycle 4) $429,006
University of California, San Francisco Tobacco-Use Prevention and Cessation

Effects of Environmental Tobacco Smoke on Pulmonary Allergy 1995 (Cycle 4) $256,805
University of California, Davis Pulmonary Disease

Passive Smoking: Role of Airways Reactivity in Infancy 1995 (Cycle 4) $486,888
University of California, Berkeley Epidemiology

Expressing & Cloning of ATP-Sensitive Potassium Channels 1995 (Cycle 4) $286,163
University of California, Santa Barbara Cardiovascular Disease

Calorigenic and Atherogenic Effects of Smoking and Nicotine 1995 (Cycle 4) $357,492
University of California, San Francisco Cardiovascular Disease

Hemoglobin Conversion to Pro-Oxidants by Cigarette Smoke 1995 (Cycle 4) $454,365
Lawrence Berkeley National Laboratory Cardiovascular Disease

Smoking, Personality and the Risk of Parkinson's Disease 1995 (Cycle 4) $297,245
Kaiser Foundation Research Institute Epidemiology

Function and Regulation of the Retinoblastoma Protein 1995 (Cycle 4) $385,031
University of California, San Diego Cancer

A Methodological Multi-Ethnic Study of Smoking Initiation 1995 (Cycle 4) $260,978
University of California, Los Angeles Tobacco-Use Prevention and Cessation

Developmental Relationship between NK and T-Cell Lineages 1995 (Cycle 4) $434,126
California Institute of Technology Cancer

Proteins that Remove Atherogeneic Lipoproteins from Blood 1995 (Cycle 4) $678,254
J. David Gladstone Institutes Cardiovascular Disease

Suppression of Oncogenic Ras Mutations 1995 (Cycle 4) $348,032
University of California, Berkeley Cancer

Electrophysiological Effects of Perinatal Nicotine Exposure 1995 (Cycle 4) $293,752
San Diego State University Research Foundation General Biomedical Science

-Heterologous Expression of Brain Nicotinic Acetylcholine Re 1995 (Cycle 4) $598,774
California Institute of Technology Nicotine Dependence

Gene Markers for Hypertension 1995 (Cycle 4) $356,151
University of California, San Francisco Cardiovascular Disease

NMR Study of 13C Edatrexate Metabolism 1995 (Cycle 4) $258,990
University of California, Davis Cancer

Effect of Tobacco on Rat Lung Alveolar Lining Liquid 1995 (Cycle 4) $643,213
Lawrence Berkeley National Laboratory Pulmonary Disease

Tumor-Specific Vascular Proteins in Lung Cancer 1995 (Cycle 4) $105,294
University of California, San Diego Cancer

H-Ras Ribozyme Mediated Tumor Suppression of BUX Cells 1995 (Cycle 4) $352,183
City of Hope National Medical Center Cancer

Role of Ah Receptor Nuclear Translocator in Carcinogenesis 1995 (Cycle 4) $140,096
University of California, Los Angeles Cancer

Reduction of Passive Smoking in Asthmatic Children 1995 (Cycle 4) $282,971
San Diego State University Research Foundation Tobacco-Use Prevention and Cessation

Cardiac Arrythmias Before and After Smoking Cessation 1995 (Cycle 4) $93,780
University of California, San Francisco Cardiovascular Disease

Detrimental Influence of Nitric Oxide on Vascular Function 1995 (Cycle 4) $8,965
University of California, Los Angeles Cardiovascular Disease

Quality of Tobacco Industry Funded Research 1995 (Cycle 4) $152,885
University of California, San Francisco Public Health, Public Policy, and Economics

Electrophysiological Effects of Perinatal Nicotine Exposure 1995 (Cycle 4) $446,225
Scripps Research Institute General Biomedical Science

Membrane Signaling Pathways of RAS/RAB Proteins 1995 (Cycle 4) $574,559
Scripps Research Institute Cancer

Structure-Function Correlations for Ras p21 and its Mutants 1995 (Cycle 4) $322,049
University of Southern California Cancer

Clinical Pharmacology of Tobacco Alkaloids 1995 (Cycle 4) $393,855
University of California, San Francisco General Biomedical Science

Transcriptional Regulation of Programmed Cell Dealth 1995 (Cycle 4) $304,418
University of California, Berkeley Cancer

Ad and Movie Imagery and Teen's Perceptions About Smokers 1995 (Cycle 4) $190,616
University of California, Irvine Public Health, Public Policy, and Economics

The Dopamine D2 Receptor in Nicotine Addiction 1995 (Cycle 4) $304,790
City of Hope National Medical Center General Biomedical Science

Vasoactive Mediators of Fetal Growth Retardation 1995 (Cycle 4) $615,296
Cedars-Sinai Medical Center Epidemiology

Nicotine and Smoking Effects on Neuromuscular Development 1995 (Cycle 4) $412,639
Cedars-Sinai Medical Center Pulmonary Disease

Roles of Hypoxia, Nicotine, & Camp in Ischemic Heart Failure 1995 (Cycle 4) $746,727
SRI International Cardiovascular Disease

Identification on Tumors of Molecular Targets for NK Cells 1995 (Cycle 4) $314,006
University of California, San Francisco Cancer

Effects of Tobacco Smoke on Mucin Production in Rat Airways 1995 (Cycle 4) $356,400
University of California, San Francisco Pulmonary Disease

Passive Smoking and Clara Cell Development in the Lungs 1995 (Cycle 4) $442,317
University of California, Davis Pulmonary Disease

Fertility, Smoking, and Early Mammalian Development 1995 (Cycle 4) $321,193
University of California, Riverside General Biomedical Science

Smoking, Free Radicals, Antioxidants and Disease Prevention 1995 (Cycle 4) $408,853
University of California, Berkeley Pulmonary Disease

Control of Mucociliary Clearance in the Respiratory Tract 1995 (Cycle 4) $276,780
University of California, Los Angeles Pulmonary Disease

Benzo[a]pyrene: Biogenetic Effects on Hepatocytes in Vitro 1995 (Cycle 4) $321,199
University of California, San Diego Cancer

Determinants of Susceptibility to Oxidized Lipoproteins 1995 (Cycle 4) $495,384
University of California, Los Angeles Cardiovascular Disease

Cellular Defects in Lung caused by Tobacco Smoke 1995 (Cycle 4) $319,013
University of California, San Francisco Pulmonary Disease

A Smokeless Tobacco Cessation Program: High School Athletes 1995 (Cycle 4) $533,923
University of California, San Francisco Tobacco-Use Prevention and Cessation

Effect of Smoking on Success Rate of In Vitro Fertilization 1995 (Cycle 4) $449,805
University of California, San Diego Epidemiology

1994 (Cycle 3)
Defensins and à2-macroglobulin in Lung Inflammation 1994 (Cycle 3) $316,269
University of California, Los Angeles Pulmonary Disease

Role of Protein Phosphatase 2A in Lung Carcinoma 1994 (Cycle 3) $342,144
University of California, San Diego Cancer

Environmental Tobacco Smoke and Lung Cancer 1994 (Cycle 3) $234,432
University of California, Davis Cancer

Mechanisms Underlying Smoking-Induced Oxidation of LDL 1994 (Cycle 3) $264,586
University of California, San Diego Cardiovascular Disease

Desensitization of Cholinergic Mechanisms & Nicotine Addictn 1994 (Cycle 3) $267,178
University of California, Davis Nicotine Dependence

Tobacco Smoking & Genetic Alterations in Bladder Epithelium 1994 (Cycle 3) $282,853
University of California, San Francisco Cancer

Diagnosis and Treatment of MTAse-Deficient Lung Cancers 1994 (Cycle 3) $370,631
University of California, San Diego Cancer

Environmental Tobacco Smoke and Fetal Growth Retardation 1994 (Cycle 3) $124,865
University of California, Davis General Biomedical Science

Role of Annexins in Neutrophil Degranulation 1994 (Cycle 3) $422,822
University of California, San Francisco Pulmonary Disease

Role of aV Integrins in Malignancy of Tobacco/Induced Tumors 1994 (Cycle 3) $485,909
Scripps Research Institute Cancer

Smoking Cessation After Surgery/A Randomized Trial 1994 (Cycle 3) $378,222
University of California, San Francisco Tobacco-Use Prevention and Cessation

The Dopamine D2 Receptor in Nicotine Addiction 1994 (Cycle 3) $162,870
City of Hope National Medical Center Nicotine Dependence

Correlates of Smoking in Teen, Adult & Pregnant Women in CA 1994 (Cycle 3) $136,082
University of California, San Francisco Public Health, Public Policy, and Economics

The Character, Costs, and Impacts of Public Smoking Programs 1994 (Cycle 3) $137,264
University of California, Berkeley Public Health, Public Policy, and Economics

Tobacco Prevention for Hard to Reach Youth 1994 (Cycle 3) $224,497
San Diego State University Research Foundation Tobacco-Use Prevention and Cessation

Cell Adhesion Receptors in Atherogenesis 1994 (Cycle 3) $391,252
Scripps Research Institute Cardiovascular Disease

Regulation of GP IIb-IIIa by the Platelet Cytoskeleton 1994 (Cycle 3) $537,597
Children's Hospital Oakland Research Institute Cardiovascular Disease

Oral Clefts, Candidate Genes, & Parental Tobacco Use 1994 (Cycle 3) $253,154
March of Dimes Birth Defects Foundation Epidemiology

Pathogenesis of Smoke-Induced Injury in Airway Epithelium 1994 (Cycle 3) $431,266
University of California, Davis Pulmonary Disease

Genetic Markers of Lung Cancer Risk Among Blacks & Whites 1994 (Cycle 3) $295,028
University of Southern California Epidemiology

Modeling US Lung Cancer Death Rates 1994 (Cycle 3) $158,756
University of California, San Diego Epidemiology

Signal Transduction and Cell Activation 1994 (Cycle 3) $404,312
Salk Institute for Biological Studies Cancer

Smoking and HDL Cholesterol in Minority Youth 1994 (Cycle 3) $669,343
University of Southern California Epidemiology

Cloning & Expression of the Apo-B mRNA Editing Factor 1994 (Cycle 3) $254,743
J. David Gladstone Institutes Cardiovascular Disease

Hormones and Tobacco: Joint Effects on Reproduction 1994 (Cycle 3) $263,611
Public Health Institute Epidemiology

Does TGF-b modulate Metastasis of Small Cell Lung Carcinoma 1994 (Cycle 3) $389,719
University of California, San Francisco Cancer

Smoking and Risk of Proximal Vs. Distal Gastric Cancer 1994 (Cycle 3) $835,887
University of Southern California Epidemiology

T-Cell Stimulating Antigen Genes in Tumor Cells 1994 (Cycle 3) $362,814
University of California, Berkeley Cancer

Integrin Cytoplasmic Domains and Ligand Affinity Modulation 1994 (Cycle 3) $522,649
Scripps Research Institute Cardiovascular Disease

Weight Gain as a Predictor of Smoking Relapse 1994 (Cycle 3) $750,320
SRI International Tobacco-Use Prevention and Cessation

Smokeless Tobacco Cessation Among Lumber Mill Employees 1994 (Cycle 3) $159,203
University of Southern California Tobacco-Use Prevention and Cessation

Monocyte Chemoattractant Protein (MCP-1) in Atherosclerosis 1994 (Cycle 3) $484,207
J. David Gladstone Institutes Cardiovascular Disease

Sites of Chemoattractant Receptor Interaction with G Protein 1994 (Cycle 3) $720,174
Scripps Research Institute Pulmonary Disease

Smoking and Arterial Flux of Low Density Lipoprotein 1994 (Cycle 3) $274,674
University of California, Davis Cardiovascular Disease

Acetylcholine Receptors in the Developing Nervous System 1994 (Cycle 3) $116,263
University of California, San Diego Nicotine Dependence

Smoking Related Abnormalities of the Lung Surfactant System 1994 (Cycle 3) $438,278
University of California, San Diego Pulmonary Disease

Regulation of Natural Killer Cell Activity by Theophylline 1994 (Cycle 3) $172,231
University of California, Los Angeles Pulmonary Disease

Nicotine & Cocaine Dynamics: Patterns & Consequences 1994 (Cycle 3) $277,738
University of California, Los Angeles Public Health, Public Policy, and Economics

Effects of Tobacco Smoke on Proto-Oncogene Activity 1994 (Cycle 3) $382,758
University of California, San Diego Cancer

Functional Synthetic Peptide Mimics of Apolipoprotein E 1994 (Cycle 3) $653,578
Scripps Research Institute Cardiovascular Disease

Na/H Exchange in Hypoxic/Ischemic Myocardium: Effects on Ca 1994 (Cycle 3) $243,322
University of California, Davis Cardiovascular Disease

Mechanism of Mitotic Chromosome Condensation 1994 (Cycle 3) $292,842
University of California, San Francisco Cancer

Periodic Gene Expression in the G1 Phase of the Cell Cycle 1994 (Cycle 3) $498,844
California Institute of Technology Cancer

Tobacco Smoke Exposure & Chromosomally Defective Sperm 1994 (Cycle 3) $438,464
Lawrence Livermore National Laboratory Epidemiology

Sidestream Tobacco Smoke Dispersion and Inhalability 1994 (Cycle 3) $265,856
University of California, Irvine General Biomedical Science

Radioimmunotherapy & Hypoxic Cytotoxin in Squamous Cancer 1994 (Cycle 3) $157,321
SRI International Cancer

Role of the Acetyl LDL Receptor in Atherogenesis 1994 (Cycle 3) $121,187
J. David Gladstone Institutes Cardiovascular Disease

Response of Respiratory Cancers to Novel Antiofolates 1994 (Cycle 3) $175,926
University of Southern California Cancer

Effect of Maternal Smoking on Human Placental Development 1994 (Cycle 3) $406,527
University of California, San Francisco General Biomedical Science

D2 Dopamine Receptor Alleles in Smokers & Nonsmokers 1994 (Cycle 3) $356,559
University of California, Los Angeles Public Health, Public Policy, and Economics

Radioimmunotherapy of Lung Cancer 1994 (Cycle 3) $318,994
University of Southern California Cancer

Cell Adhesion Receptors in Atherogenesis 1994 (Cycle 3) $170,341
The Burnham Institute for Medical Research Cardiovascular Disease

Effects of Nicotine on Weight 1994 (Cycle 3) $136,752
Stanford University General Biomedical Science

Autocrine Interactions Between Bombesin and its Receptor 1994 (Cycle 3) $316,238
University of California, San Diego Cancer

Role of Nitric Oxide in Smoking-Related Vascular Impotence 1994 (Cycle 3) $531,486
LA Biomedical Research Institute at Harbor-UCLA Medical Center Cardiovascular Disease

1993 (Cycle 2)
Clinician Initiated Smoking Prevention: A Controlled Trial 1993 (Cycle 2) $2,071,588
San Diego State University Research Foundation Tobacco-Use Prevention and Cessation

Effect of Cigarette Smoke on High Risk Lipoprotein Profiles 1993 (Cycle 2) $332,996
Lawrence Berkeley National Laboratory Cardiovascular Disease

Oral Cancer: Adhesive Interactions During Progression 1993 (Cycle 2) $182,765
University of California, San Francisco Cancer

Smoke Induced Differntial Expression of Cellular Proteins 1993 (Cycle 2) $257,010
University of California, San Francisco Pulmonary Disease

Smoking-Induced Impairment of Pulmonary Host Defense 1993 (Cycle 2) $381,970
University of California, Irvine Pulmonary Disease

Analysis of Retinoid Mediated Anti-cancer Activities 1993 (Cycle 2) $757,415
The Burnham Institute for Medical Research Cancer

Role of Elastin Peptides in Neutrophil-Mediated Lung Injury 1993 (Cycle 2) $495,336
Childrens Hospital, Los Angeles Pulmonary Disease

Nicotine Addiction: Novel ACh Receptors on Neurons 1993 (Cycle 2) $369,025
University of California, San Diego Nicotine Dependence

CNS effects of prenatal nicotine exposure: threshold dosage 1993 (Cycle 2) $458,763
LA Biomedical Research Institute at Harbor-UCLA Medical Center Nicotine Dependence

Expression of a drug resistance gene in head and neck cancer 1993 (Cycle 2) $337,086
University of California, San Diego Cancer

Nicotinic Receptors, Tolerance and Spinal Neurotransmitters 1993 (Cycle 2) $320,869
University of California, San Diego Nicotine Dependence

Modifiers of susceptibility to smoking for lung cancer 1993 (Cycle 2) $201,856
University of Southern California Epidemiology

Advances in Lung Cancer Detection with Digital Techniques 1993 (Cycle 2) $276,730
University of California, Los Angeles Cancer

Smoking as a risk factor in the etiology of down syndrome 1993 (Cycle 2) $730,292
March of Dimes Birth Defects Foundation Epidemiology

Regulation of Oxidant Production in Activated Phagocytes 1993 (Cycle 2) $540,379
Scripps Research Institute Pulmonary Disease

Asymmetric Synthesis of (-)-Podophyllotoxin 1993 (Cycle 2) $121,946
University of California, Santa Cruz Cancer

Determinants of Thrombin Interaction With Its Receptor 1993 (Cycle 2) $264,243
University of California, San Francisco Cardiovascular Disease

Smoking and Leukemia: A Molecular Genetic Approach 1993 (Cycle 2) $334,253
University of California, Los Angeles Cancer

Control of breathing in infants of smoking mothers 1993 (Cycle 2) $290,986
California Pacific Medical Center Research Institute Epidemiology

Smoking Cessation in Recovering Alcoholic Person (SCRAP) 1993 (Cycle 2) $835,924
San Diego State University Research Foundation Tobacco-Use Prevention and Cessation

Sucellular Localization of CAMP-dependent Protein Kinase 1993 (Cycle 2) $338,472
University of California, San Diego Cancer

Nicotine, Tobacco Smoke and the Blood-Brain Barrier 1993 (Cycle 2) $624,017
University of Southern California Nicotine Dependence

Fertility, Smoking, and Early Mammalian Development 1993 (Cycle 2) $166,751
University of California, Riverside General Biomedical Science

Health Related Quality of Life Outcomes of Smokers Who Quit 1993 (Cycle 2) $338,364
University of California, San Francisco Public Health, Public Policy, and Economics

Measurement & Outcomes of Dyspnea in COPD 1993 (Cycle 2) $193,253
University of California, San Diego Pulmonary Disease

Modeling U.S. Lung Cancer Death Rates 1993 (Cycle 2) $127,276
University of California, San Diego Epidemiology

Statistics of Tobacco Smoke Exposure 1993 (Cycle 2) $910,542
Stanford University Epidemiology

Tobacco Smoke and Airway Fluid Transport & Composition 1993 (Cycle 2) $301,622
University of California, Riverside Pulmonary Disease

Vascular Effects of Nicotine: Effect of Age 1993 (Cycle 2) $331,124
University of California, Irvine Nicotine Dependence

Effect of Cigarette Smoke on Vascular Wall Permeability 1993 (Cycle 2) $99,854
University of California, Davis Cardiovascular Disease

Phosphoryl Peptide Inhibitors of Tyrosine Kinases 1993 (Cycle 2) $308,697
University of California, San Francisco Cancer

Angiotensin II and Restenosis after Coronary Angioplasty 1993 (Cycle 2) $228,018
University of California, Davis Cardiovascular Disease

Tobacco Induced Hypoxia: Molecular Genetic Responses 1993 (Cycle 2) $685,782
University of Southern California Cardiovascular Disease

Apolipoprotein(a) and Cardiovascular Disease 1993 (Cycle 2) $590,733
Stanford University Cardiovascular Disease

Activated Protein C in Smokers Thrombosis 1993 (Cycle 2) $347,737
Scripps Research Institute Cardiovascular Disease

The Effect of Cigarette Smoke on Airway Neuronal Receptors 1993 (Cycle 2) $225,260
University of California, San Francisco Pulmonary Disease

Tobacco Product Modulation of TNF Responses in Lung Cells 1993 (Cycle 2) $371,620
University of California, Riverside General Biomedical Science

Steroid Influences on Diaphragm Performance in Emphysema 1993 (Cycle 2) $343,914
Cedars-Sinai Medical Center Pulmonary Disease

Smoking and Lipoprotein-Based Mechanisms of Atherogenesis 1993 (Cycle 2) $250,645
University of California, San Francisco Cardiovascular Disease

Do Follow-up Visits Help Patients Quit Smoking? 1993 (Cycle 2) $745,189
University of California, San Francisco Tobacco-Use Prevention and Cessation

The Effects of Tobacco Smoke on Airway Mucin mRNA 1993 (Cycle 2) $71,867
University of California, San Francisco Pulmonary Disease

Smoking-Related Advertising and Preteens' Social Perceptions 1993 (Cycle 2) $72,837
University of California, Irvine Public Health, Public Policy, and Economics

Effect of Single-Session Hypnosis on Smoking Cessation 1993 (Cycle 2) $610,950
Stanford University Tobacco-Use Prevention and Cessation

Tobacco-Related Disease Trends among 118,000 Californians 1993 (Cycle 2) $236,471
University of California, Los Angeles Epidemiology

Relating Tobacco Access and Consumption Among Youth 1993 (Cycle 2) $489,771
Stanford University Tobacco-Use Prevention and Cessation

Radon Attachment to Cigarette Smoke Aerosols 1993 (Cycle 2) $344,430
Lawrence Livermore National Laboratory General Biomedical Science

The Cost of Passive Smoking on Children's Health 1993 (Cycle 2) $242,086
RAND Corporation Public Health, Public Policy, and Economics

Ethnicity and the Meaning of Smoking in Older Age Groups 1993 (Cycle 2) $317,076
University of California, San Francisco Public Health, Public Policy, and Economics

Smoking Ordinances, Passive Smoking and Smoking Cessation 1993 (Cycle 2) $151,547
Molecular Medicine Research Institute Public Health, Public Policy, and Economics

Structure-function studies of RAS nucleotide-exchange-factor 1993 (Cycle 2) $593,460
University of Southern California Cancer

1992 (Cycle 1)
Determinants of Susceptibilty to Oxidixed Lipoproteins 1992 (Cycle 1) $324,569
University of California, Los Angeles Cardiovascular Disease

Lung Cancer: p53 as a Paradigm of Tumor Suppression 1992 (Cycle 1) $138,420
Cedars-Sinai Medical Center Cancer

Lung Cancer: p53 as a Paradigm of Tumor Suppression 1992 (Cycle 1) $327,795
University of California, Los Angeles Cancer

Tobacco Carcinogen Transformation of Human Bronchial Cells 1992 (Cycle 1) $621,592
University of Southern California Cancer

Regulation of the Nicotinic Receptors by Nicotine 1992 (Cycle 1) $756,102
Salk Institute for Biological Studies Nicotine Dependence

Heterologous Expression of Brain Nicotinic Receptors 1992 (Cycle 1) $586,840
California Institute of Technology Nicotine Dependence

Nicotinic Effects on Gene Expression in PC-12 Cells 1992 (Cycle 1) $266,647
University of California, San Diego Nicotine Dependence

Nicotine Enhanced Adrenal Medullary-Dependent Inflammation 1992 (Cycle 1) $363,563
University of California, San Francisco Nicotine Dependence

Tobacco Carcinogens/C-Kinase Oxidative Activation/Metastasis 1992 (Cycle 1) $363,557
University of Southern California Cancer

Thrombin Function/Inhibition in Tobacco-Related Diseases 1992 (Cycle 1) $578,441
SRI International Cardiovascular Disease

Pathways for Reverse Cholesterol Transport 1992 (Cycle 1) $265,990
University of California, San Diego Cardiovascular Disease

Passive Smoking & Clara Cell Developement in the Lungs 1992 (Cycle 1) $435,023
University of California, Davis Pulmonary Disease

Pathogenesis of Cigarette Smoke-Induced Bronchitis 1992 (Cycle 1) $487,719
University of California, Davis Pulmonary Disease

Predictors of Weight Gain After Smoking Cessation 1992 (Cycle 1) $809,412
Kaiser Foundation Research Institute Tobacco-Use Prevention and Cessation

Environmental & Genetic Risk Factors for Bladder Cancer 1992 (Cycle 1) $1,147,940
University of Southern California Epidemiology

Nicotine, Hypertension & Induction of Aortic Disease 1992 (Cycle 1) $182,010
University of California, Davis Cardiovascular Disease

CNS Processing of Lung Afferent & Cigarette Smoke Inputs 1992 (Cycle 1) $261,726
University of California, Davis Pulmonary Disease

Roles of Hypoxia, Nicotine & cAMP in Ischemic Heart Failure 1992 (Cycle 1) $713,367
SRI International Cardiovascular Disease

Complement Mediated Cardiac Ischemei & Thromboxane Release 1992 (Cycle 1) $291,601
Veterans Medical Research Foundation Cardiovascular Disease

Oxygen Effects on Flow & function in Ischemic Myocardium 1992 (Cycle 1) $278,044
University of California, San Francisco Cardiovascular Disease

Effects of Sedatives on Neuronal Nicotinic Binding 1992 (Cycle 1) $394,301
University of California, San Francisco Nicotine Dependence

Interaction of Complement C4b-Binding Protein with Protein B 1992 (Cycle 1) $616,016
Scripps Research Institute General Biomedical Science

Peptidyl Phosphonate Inhibitors to Human Leukocyte Elastase 1992 (Cycle 1) $359,461
SRI International General Biomedical Science

Characterization of Particulate-Phase ETS in Differing Envir 1992 (Cycle 1) $454,509
Lawrence Berkeley National Laboratory General Biomedical Science

Factors Required for K-RAS 4B Membrane Association/Activity 1992 (Cycle 1) $600,414
Scripps Research Institute General Biomedical Science

Novel Benzoxazinone Inhibitors to Hunam Leukocyte Elastase 1992 (Cycle 1) $332,615
SRI International General Biomedical Science

The Mechanism of Nicotine-Induced Gastric Mucosal Injury 1992 (Cycle 1) $221,032
University of California, Los Angeles General Biomedical Science

Effectiveness Ventilation & other Controls in Reducing ETS 1992 (Cycle 1) $522,494
Public Health Foundation Enterprises, Inc. General Biomedical Science

An Endogenous Lectin in Airway Epithelium & Lung Cancer 1992 (Cycle 1) $463,703
University of California, San Francisco Pulmonary Disease

Control of Differentiation of the Early Embryonic Heart 1992 (Cycle 1) $191,398
California Institute of Technology Cardiovascular Disease

Mechanism of Endothelin-Stimulated ANF Secretion 1992 (Cycle 1) $447,480
San Diego State University Research Foundation Cardiovascular Disease

Doses to Target Tissues from Inhaled Tobacco Smoke 1992 (Cycle 1) $413,410
University of California, Irvine General Biomedical Science

Effects of Prenatal Nicotine Exposure in Brain Development 1992 (Cycle 1) $750,511
University of Southern California General Biomedical Science

Genetic Aberrations in Tobacco-Related Lung Carcinogenesis 1992 (Cycle 1) $214,126
University of Southern California Cancer

Involvement of the Tumor Suppressor Gene p53 in Lung Cancer 1992 (Cycle 1) $112,504
University of California, Irvine Cancer

Lung Cancer Associated Retinopathy 1992 (Cycle 1) $352,945
University of California, Davis Cancer

Monoclonal Antibody-Drug Conjugate Treatment of Lung Cancer 1992 (Cycle 1) $258,750
Scripps Clinic & Research Foundation Cancer

Integrin Distribution & Function in Lung Carcinoma Cells 1992 (Cycle 1) $358,128
University of California, San Francisco Cancer

Role of Nicotine in Enodthelial Cell Function 1992 (Cycle 1) $274,274
University of Southern California Cardiovascular Disease

Modulatory Effects of Tobacco Products in Immune Function 1992 (Cycle 1) $85,387
University of California, San Diego General Biomedical Science

Effects of Smoking on Metabolism During Rest & Exercise 1992 (Cycle 1) $504,382
University of California, Berkeley Pulmonary Disease

Carotid Body Amplification of Exertional Dyspnea in Smokers 1992 (Cycle 1) $196,560
University of California, Los Angeles Pulmonary Disease

Smoking, Immunoglobulin E, & Cardiovascular Disease 1992 (Cycle 1) $49,517
University of California, San Diego Epidemiology

Amnesty Smoking Prevention Project 1992 (Cycle 1) $686,087
University of Southern California Tobacco-Use Prevention and Cessation

Cost of Smoking in California 1992 (Cycle 1) $185,697
University of California, San Francisco Public Health, Public Policy, and Economics

Physician Incentives & Smoking Cessation Effectiveness 1992 (Cycle 1) $745,316
University of Southern California Tobacco-Use Prevention and Cessation

Impact of Caffeine Use On Tobacco Cessation & Withdrawal 1992 (Cycle 1) $377,968
Loma Linda University Tobacco-Use Prevention and Cessation

Case study on tobacco use legislation 1992 (Cycle 1) $160,907
RAND Corporation Public Health, Public Policy, and Economics

Comparison of Nicotine Metabolism in four Ethnic Groups 1992 (Cycle 1) $449,327
University of California, San Francisco Public Health, Public Policy, and Economics

Tobacco Industry Response to Passive Smoking 1992 (Cycle 1) $484,233
University of California, San Francisco Public Health, Public Policy, and Economics

Experimental Approach to Tobacco Control for Hi-Risk Teens 1992 (Cycle 1) $672,155
San Diego State University Research Foundation Tobacco-Use Prevention and Cessation

The Role of Sleep in Successful Smoking Cessation 1992 (Cycle 1) $180,399
Long Beach Research Foundation Tobacco-Use Prevention and Cessation

Laboratory & Ambulatory Assessment of Smoking Withdrawal 1992 (Cycle 1) $385,814
SRI International Tobacco-Use Prevention and Cessation

Differentiating Preadolescent/Adolescent Paths to Smoking 1992 (Cycle 1) $459,986
University of Southern California Public Health, Public Policy, and Economics

Controlling Exposure to Environmental Tobacco Smoke 1992 (Cycle 1) $205,357
University of California, Berkeley General Biomedical Science

Neutrophil Cytostatic Activity Against Lung Tumor Cells 1992 (Cycle 1) $223,628
University of California, Los Angeles Cancer

Smoking & Atherosclerosis--An Autoimmune Phenomenon? 1992 (Cycle 1) $151,149
University of California, Davis Cardiovascular Disease

Prop99 & Indigent Care:Lessons for Future Health Care Reform 1992 (Cycle 1) $589,892
University of California, San Francisco Public Health, Public Policy, and Economics

Assessing Tobacco Refusal Skills in Latino Youth 1992 (Cycle 1) $584,719
San Diego State University Research Foundation Public Health, Public Policy, and Economics

A Smokeless Tobacco Cessation Intervention:College Athletes 1992 (Cycle 1) $648,997
University of California, San Francisco Tobacco-Use Prevention and Cessation

Management of Smoking by the Elderly in Long Term Care 1992 (Cycle 1) $498,334
University of California, San Francisco Public Health, Public Policy, and Economics

Pregnant Smokers: Predictors of Cessation & Relapse 1992 (Cycle 1) $451,831
University of California, San Francisco Tobacco-Use Prevention and Cessation

Effects of Social & Personal Coping Programs for Smok Prev 1992 (Cycle 1) $676,689
University of Southern California Tobacco-Use Prevention and Cessation

Reduction of Passive Smoking in Asthmatic Children: Clinical 1992 (Cycle 1) $521,489
San Diego State University Research Foundation Tobacco-Use Prevention and Cessation

Risks for Selected Birth Defects from Parental Cig Smoke 1992 (Cycle 1) $560,383
March of Dimes Birth Defects Foundation Epidemiology

Nicotine Levels in Pregnant Women & Child Development 1992 (Cycle 1) $335,068
University of California, Berkeley Epidemiology

Filipino Smoking Prevalance Survey in California 1992 (Cycle 1) $153,533
Asian & Pacific Islander American Health Forum Epidemiology

Smoking-Induced Mod. of Resp. Burst Oxidase of Human Phagocy 1992 (Cycle 1) $298,435
University of California, San Diego Pulmonary Disease

Molecular Mechanisms of Leukocyte Traffic to the Lungs 1992 (Cycle 1) $345,676
Stanford University Pulmonary Disease

Tobacco Smoke: Mechanistic Roles in COPD 1992 (Cycle 1) $250,297
University of California, Davis Pulmonary Disease

Effects of Tobacco on Rat Lung Alveolar Lining Liquid 1992 (Cycle 1) $417,585
Lawrence Berkeley National Laboratory Pulmonary Disease

In Vitro Characterization of Human Airway Gland Cells 1992 (Cycle 1) $511,793
University of California, San Francisco Pulmonary Disease

Substrate Cycles, Calorigenesis & Smoking Cessation 1992 (Cycle 1) $378,709
University of California, San Francisco Public Health, Public Policy, and Economics

Smoking & Adverse Reproductive Health Effects in Women 1992 (Cycle 1) $550,243
University of California, Davis Epidemiology

Cigarette Smoking & Sudden Cardiac Death 1992 (Cycle 1) $783,629
University of California, San Francisco Epidemiology

Tobacco & Its Releated Diseases: Law, Policy & Politics 1992 (Cycle 1) $218,932
University of California, Berkeley Public Health, Public Policy, and Economics

Smoking & Passive Smoking Patterns in Chinese Americans 1992 (Cycle 1) $524,884
Public Health Institute Epidemiology

The Relationship of Tobacco Exposure to Semen Biomarkers 1992 (Cycle 1) $186,739
University of California, San Francisco Epidemiology

Smoking Effects on Maternal Folate & Reproductive Outcomes 1992 (Cycle 1) $105,988
University of California, Davis Epidemiology

Effect of Tobacco in Cervical Neoplasia in Young Women 1992 (Cycle 1) $959,796
University of California, San Francisco Epidemiology

Cigarette Smoking & Facial Wrinkling 1992 (Cycle 1) $515,796
University of California, San Francisco Epidemiology

Role of Smoking in Progression of Anal Neoplasia 1992 (Cycle 1) $638,812
University of California, San Francisco Epidemiology

Surveillance for Tobacco-Related Diseases 1992 (Cycle 1) $627,384
Public Health Institute Public Health, Public Policy, and Economics

Effects of Smoke on Fluid Transport Across Trachea 1992 (Cycle 1) $395,115
University of California, Berkeley Pulmonary Disease

Prospective Study of Cigarette Smoking & Behavior Dysfunctn 1992 (Cycle 1) $500,370
University of California, Berkeley Public Health, Public Policy, and Economics

Nicotine Effects on Activity of Brain Catecholamine Neurons 1992 (Cycle 1) $317,443
University of California, San Diego Nicotine Dependence

Effects of Smoking on High Density Lipoprotein Species 1992 (Cycle 1) $203,942
University of California, San Francisco Cardiovascular Disease

Clinical Pharmacology of Tobacco Alkaloids 1992 (Cycle 1) $538,143
University of California, San Francisco Public Health, Public Policy, and Economics

Nicotine & Early Response Gene Expression in Brain 1992 (Cycle 1) $99,290
University of California, San Francisco Nicotine Dependence

Self Management for Tobacco-Related Chronic Diseases 1992 (Cycle 1) $1,049,257
Stanford University Public Health, Public Policy, and Economics

Adenosine Airway Reactivity & Receptors in Smokers 1992 (Cycle 1) $93,500
University of California, Davis Pulmonary Disease

Pulmonary Benzo(A)pyrene Metabolism & Tobacco Smoking 1992 (Cycle 1) $303,996
University of California, Irvine Pulmonary Disease

Effects of Passive Smoking on Experimental Atherosclerosis 1992 (Cycle 1) $340,594
University of California, San Francisco Cardiovascular Disease

Effects of Nicotine on Human Information Processing 1992 (Cycle 1) $247,818
Northern California Institute for Research & Education Public Health, Public Policy, and Economics

Effects of Nicotine on Human Information Processing 1992 (Cycle 1) $91,817
University of California, San Francisco Public Health, Public Policy, and Economics

A Genetic Marker of Lung Cancer Risk Among Blacks & Whites 1992 (Cycle 1) $1,036,615
University of Southern California Epidemiology

The Accumbens: A Critical Brain Site for Nicotine Craving 1992 (Cycle 1) $532,964
Scripps Research Institute Nicotine Dependence

Cigarette Smoking, Steroidogenesis & Steroid Receptors 1992 (Cycle 1) $316,942
Stanford University General Biomedical Science

Modifiers of Susceptibility to Smoking for Lung Cancer 1992 (Cycle 1) $79,865
University of Southern California Epidemiology

Analysis of the Effect of Natl Policies on Smoking Behavior 1992 (Cycle 1) $579,489
University of California, San Diego Public Health, Public Policy, and Economics

Cloning of Two Genes Involved it Tobacco Carcinogenesis 1992 (Cycle 1) $323,634
University of California, Los Angeles Cancer

Tumor Suppressor Genes in Human Lung Cancer 1992 (Cycle 1) $319,060
University of California, Irvine Cancer

Optical Partical Size Measurements of Tobacco Smoke 1992 (Cycle 1) $103,468
University of California, Irvine General Biomedical Science

Determinants of Maximum Oxygen Transport. 1992 (Cycle 1) $282,699
University of California, San Diego Pulmonary Disease

Tobacco-Related Disease in Native California Twins 1992 (Cycle 1) $634,515
University of Southern California Epidemiology

Pulmonary Vascular Leukocytes & Tobacco Products 1992 (Cycle 1) $435,721
University of California, Irvine Pulmonary Disease

Protection of Lung Epithelium by Heat Shock Proteins 1992 (Cycle 1) $357,085
University of California, Irvine Pulmonary Disease

Vascular Response to Injury: Potentiation by Nicotine 1992 (Cycle 1) $572,478
Stanford University Cardiovascular Disease

Tumor Infiltrating Lymphocytes & Pulmonary Macrophages 1992 (Cycle 1) $423,786
University of California, Los Angeles Cancer

Stress & Smoking in Natural Settings: An Ambulatory Study 1992 (Cycle 1) $489,853
University of California, Los Angeles Public Health, Public Policy, and Economics

Laryngeal Cancer Risk Factors: Tobacco Interactions 1992 (Cycle 1) $720,644
Public Health Institute Epidemiology

Benzo[A]pyrene: Biogenetic Effects on Hepatocytes in Vitro 1992 (Cycle 1) $482,971
University of California, San Diego General Biomedical Science

Environmental Tobacco Smoke & Lung Development 1992 (Cycle 1) $512,031
University of California, Irvine Pulmonary Disease

Control of Mucociliary Clearance in the Respiratory Tract 1992 (Cycle 1) $404,950
University of California, Los Angeles Pulmonary Disease

Gene Modification of Human Lung Tumor-Infiltrating Lymphocyt 1992 (Cycle 1) $152,816
University of California, Los Angeles Cancer

Precursors & Correlates of Smoking in Adolescents 1992 (Cycle 1) $63,786
Molecular Medicine Research Institute Epidemiology

Vietnamese Smoking Cessation Intervention:A Controlled Trial 1992 (Cycle 1) $707,559
University of California, San Francisco Tobacco-Use Prevention and Cessation

Detrimental Influence of NO on Vascular/Platelet Functions 1992 (Cycle 1) $288,188
University of California, Los Angeles Cardiovascular Disease

Tobacco Smoke, Free Radicals, Antioxidants & Disease 1992 (Cycle 1) $215,713
University of California, Berkeley Pulmonary Disease

Suppression of Oncogenic RAS Mutations 1992 (Cycle 1) $355,159
University of California, Berkeley Cancer

Meta-Analysis of Prop 99 Competitive Grant Funded Projects 1992 (Cycle 1) $232,993
University of California, Berkeley Public Health, Public Policy, and Economics

The Economic Effects of California Cigarette Taxation 1992 (Cycle 1) $474,976
University of California, Berkeley Public Health, Public Policy, and Economics

Interaction of Occupational Aerosols & Tobacco Smoke 1992 (Cycle 1) $192,878
University of California, Los Angeles General Biomedical Science

Vaccine Strategy Against Tumor-Associated Glycoproteins 1992 (Cycle 1) $285,227
University of California, San Diego Cancer

Novel Imuunotherapy for Small Cell Lung Carcinoma 1992 (Cycle 1) $496,569
Childrens Hospital, Los Angeles Cancer

Significance of Immune Complexes in Human Lung Carcinoma 1992 (Cycle 1) $111,083
University of California, Los Angeles Pulmonary Disease

Optim. of Train. in Patients w/Chronic Obstruc. Pulm Disease 1992 (Cycle 1) $467,503
Cedars-Sinai Medical Center Pulmonary Disease

Studies of Proto-oncogenes & Growth Genes in Human Lung Canc 1992 (Cycle 1) $336,209
University of California, Los Angeles Cancer

Early Detection of Lung Cancer with Monoclonal Antibodies 1992 (Cycle 1) $860,784
University of California, Los Angeles Cancer

Novel Approach to Head & Neck Cancer Therapy 1992 (Cycle 1) $384,743
University of Southern California Cancer

Hemoglobin Conversion to Pro-Oxidants by Cigarette Smoke 1992 (Cycle 1) $313,201
Lawrence Berkeley National Laboratory General Biomedical Science

Black-White Differences in Menthol Cigarette Smoking 1992 (Cycle 1) $332,764
University of California, Los Angeles Public Health, Public Policy, and Economics

Tobacco Cessation Among Pregnant Low-Income Latino Women 1992 (Cycle 1) $737,927
University of Southern California Tobacco-Use Prevention and Cessation

Phenols & PAH in Tobacco-Related Cardiovascular Disease 1992 (Cycle 1) $421,763
University of Southern California Cardiovascular Disease

Hospital-Based Intervention to Prevent Smoking Relapse 1992 (Cycle 1) $676,939
Stanford University Tobacco-Use Prevention and Cessation

Cigarette Smoke, Nicotine & Acid-induced Duodenal Injury 1992 (Cycle 1) $311,797
University of California, Los Angeles General Biomedical Science

Significance of Immune Complexes in Human Lung Carcinoma 1992 (Cycle 1) $249,402
John Wayne Cancer Institute Cancer